Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,11750,70,1.54 [0.42-5.72],0.5152415954347065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,11416,69,1.07 [0.70-1.63],0.7658628777842764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,13485,85,1.17 [0.84-1.63],0.3586549901852799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,11378,66,0.94 [0.50-1.78],0.8562261585219069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,13415,84,1.04 [0.75-1.45],0.8062481907344384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,13485,85,0.93 [0.70-1.23],0.6117412659832062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,11739,71,1.14 [0.98-1.33],0.1011136632051444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,11378,66,0.90 [0.63-1.28],0.5464508998908859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",13241,84,0.97 [0.77-1.21],0.7637531921004792
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",11487,69,0.80 [0.53-1.19],0.2705053157123364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",11742,71,0.96 [0.75-1.24],0.7701959402753213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,13435,82,0.97 [0.49-1.92],0.9248685697631336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,11739,71,1.16 [0.47-2.83],0.74655512924633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,13320,81,1.33 [0.95-1.86],0.0985303297555387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,11469,67,1.20 [0.61-2.39],0.5985942461932435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,11676,70,0.93 [0.76-1.13],0.4606224748256197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,13551,82,0.69 [0.45-1.05],0.0868304194630253
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,11403,65,1.15 [0.69-1.91],0.5937726183524299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,13600,86,0.98 [0.54-1.78],0.9429882182762016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,13654,85,0.82 [0.63-1.06],0.1247879906766029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,11661,71,0.97 [0.53-1.79],0.9312737118155124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,11403,65,0.89 [0.46-1.75],0.746274540000666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,11378,66,0.67 [0.31-1.48],0.324605878490833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",13320,81,1.32 [0.91-1.91],0.1468855770833388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,11378,66,0.73 [0.45-1.19],0.2035518803746313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,13286,80,1.36 [0.79-2.32],0.2662920839089261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,13444,83,1.40 [0.61-3.20],0.4307814041113462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,13551,82,1.17 [0.88-1.57],0.2842838045796972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,11378,66,0.93 [0.61-1.42],0.7341035587408109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,11420,67,0.98 [0.69-1.39],0.8963071533335805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,13708,85,1.20 [0.71-2.05],0.4982866570274868
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,13432,85,0.95 [0.60-1.51],0.835755317396309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,11403,65,1.54 [1.04-2.29],0.0322058327593534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,13320,81,1.50 [0.80-2.83],0.2058768179669398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,13466,84,1.17 [0.67-2.04],0.576667019269384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,13708,85,1.17 [0.67-2.05],0.5897492784473832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,13661,85,0.99 [0.49-1.97],0.9660946454766844
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,11676,70,1.25 [0.60-2.59],0.5486934930465115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,11403,65,0.94 [0.44-2.01],0.8778775324420203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,13714,86,0.91 [0.40-2.04],0.8138665272034915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,13485,85,1.28 [0.81-2.01],0.2854952493037545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,13320,81,1.09 [0.61-1.95],0.7796564483547598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,11403,65,0.88 [0.45-1.71],0.7053309888506981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,13584,86,1.35 [0.89-2.05],0.1639544866911259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,11721,71,1.48 [0.78-2.82],0.2277085503636391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,11416,69,0.77 [0.29-2.02],0.5981614639750366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,11742,71,1.39 [0.80-2.41],0.2394404964112572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,13241,84,1.06 [0.64-1.75],0.8202025482483738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,11469,67,1.12 [0.81-1.56],0.4931074991050174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,13444,83,2.13 [1.22-3.72],0.00816268459126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,11469,67,1.30 [0.70-2.41],0.4040462397130394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,11676,70,1.10 [0.74-1.65],0.6263585470030022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,13610,85,1.49 [0.78-2.85],0.2310967179139603
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,13636,86,1.07 [0.57-2.00],0.8319221251558288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,11742,71,1.28 [0.60-2.71],0.5263139785656947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,13485,85,0.84 [0.57-1.24],0.3738108717498546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,13551,82,1.42 [0.69-2.96],0.3415165570603738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,11396,68,0.89 [0.63-1.27],0.5293073295787114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,11469,67,0.97 [0.72-1.31],0.8650851292027225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,13320,81,1.04 [0.83-1.30],0.7474983863393242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,11750,70,0.70 [0.50-0.97],0.0336349904426933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,13675,85,1.28 [0.61-2.68],0.5076500773380117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,11378,66,0.94 [0.67-1.32],0.7188231829820986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,11469,67,0.85 [0.63-1.14],0.275266152036455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFM,Afamin,11750,70,1.60 [0.49-5.28],0.4375639440070458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,13428,82,0.86 [0.64-1.16],0.3180974030587017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,11396,68,1.26 [0.99-1.60],0.0603944803754719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,13520,84,1.02 [0.63-1.65],0.942461275411244
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,13088,80,1.04 [0.85-1.26],0.7030899401973091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,13221,83,1.10 [0.79-1.52],0.5722767313098798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,13610,85,1.24 [0.69-2.22],0.4719416610341251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,13708,85,1.34 [0.94-1.91],0.1041435958550285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,11739,71,0.72 [0.25-2.12],0.5505088580299832
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,13551,82,1.02 [0.80-1.30],0.8788617379014009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,13551,82,1.04 [0.78-1.37],0.8065633605899329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,11416,69,1.20 [0.60-2.42],0.6058129018073393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,11416,69,1.21 [0.55-2.65],0.6325190354792087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,11661,71,0.94 [0.67-1.32],0.7351791991437499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,11739,71,0.82 [0.36-1.86],0.6281929881668049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,13532,85,0.98 [0.79-1.21],0.8311823491771798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",11399,68,1.05 [0.81-1.37],0.6867609911901807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,13241,84,0.85 [0.59-1.23],0.3959730593278722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,11416,69,0.96 [0.64-1.45],0.8609287925841383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",13455,85,0.90 [0.75-1.08],0.23908029568293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,13551,82,1.12 [0.84-1.50],0.4502014226292012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",11705,70,0.97 [0.78-1.20],0.7699044654611312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,11469,67,0.84 [0.27-2.64],0.7663579789774209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,13241,84,0.87 [0.68-1.12],0.2859066828418503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,11399,68,1.02 [0.70-1.47],0.9356594665620688
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,13320,81,0.99 [0.70-1.41],0.9732059970847052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,11403,65,1.17 [0.88-1.56],0.2903141427426604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,13208,80,1.07 [0.80-1.44],0.6394023222939558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,11723,70,0.95 [0.79-1.14],0.5716362820041325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,13174,84,0.88 [0.63-1.23],0.4518412782915816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,13714,86,1.22 [0.48-3.13],0.6759151631152847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,13553,85,0.99 [0.71-1.39],0.9733372185310332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",11661,71,1.07 [0.73-1.57],0.7396611095541804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",13518,81,0.92 [0.67-1.26],0.5873051634528487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",11723,70,1.02 [0.64-1.63],0.9372589864982516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,11487,69,0.73 [0.41-1.32],0.3028248581035199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,11403,65,0.88 [0.71-1.08],0.2084774255259779
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",13485,85,1.15 [0.95-1.39],0.1576335157367978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,13286,80,0.45 [0.19-1.07],0.0693607867994882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,13659,85,1.42 [0.52-3.84],0.4916387292527762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,11721,71,0.71 [0.30-1.67],0.4334422228648815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,13208,80,0.99 [0.73-1.34],0.9406057491126494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,11399,68,1.27 [0.89-1.83],0.1877218140195476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,13485,85,0.81 [0.34-1.90],0.6218866625080286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,13286,80,1.30 [0.89-1.90],0.1767833185275079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,11469,67,0.75 [0.42-1.31],0.3049992767272742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,11633,70,1.26 [0.83-1.91],0.2778406608349237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,11705,70,1.30 [0.97-1.75],0.0824751323525111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,11001,68,0.88 [0.53-1.47],0.630904202276773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,13034,81,0.95 [0.62-1.45],0.8099522711234781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,12622,78,1.01 [0.66-1.55],0.9699702344181604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,13474,86,0.95 [0.55-1.64],0.8478865400439066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,13509,85,1.15 [0.92-1.44],0.2067905745735433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,13675,85,0.89 [0.53-1.48],0.6437887202393406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,13364,80,1.14 [0.59-2.20],0.6884550801227883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,13571,84,0.93 [0.58-1.50],0.7757766708166307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,13524,86,0.85 [0.50-1.43],0.5372981145910947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,13589,85,1.05 [0.68-1.60],0.8316277782308215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,13675,85,1.38 [0.86-2.20],0.1780883371635903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,11378,66,1.02 [0.73-1.42],0.9036547928404992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,11403,65,0.95 [0.71-1.28],0.7464124807161914
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,11316,67,0.84 [0.54-1.30],0.4233222997253804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,13241,84,1.22 [0.91-1.63],0.174810660821011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,11416,69,0.71 [0.36-1.40],0.323844664976703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,13531,85,1.69 [0.91-3.14],0.0963074265883172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,11390,67,0.82 [0.47-1.44],0.4860697556245092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,13208,80,0.82 [0.62-1.07],0.1448465334903658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,13514,80,1.03 [0.76-1.38],0.8567935485257224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,11243,69,0.89 [0.63-1.25],0.4922166443734043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,13661,85,1.04 [0.79-1.35],0.7886117993771171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,13478,82,0.93 [0.71-1.22],0.5995303736694341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,13169,79,1.28 [0.70-2.36],0.4256441387433169
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],13286,80,1.00 [0.70-1.42],0.9833345073683856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,13563,86,1.26 [0.68-2.36],0.4656043250861417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,11661,71,1.02 [0.77-1.35],0.8986777542678748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,11399,68,0.91 [0.56-1.50],0.7170937384911513
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,11676,70,1.00 [0.75-1.34],0.9944025176470016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,11705,70,0.92 [0.57-1.50],0.7516561057286415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,13485,85,1.20 [0.81-1.76],0.3676015534567061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,11649,70,1.26 [0.65-2.42],0.4915610277919235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,13634,84,1.20 [0.88-1.64],0.2463617699716526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,13551,82,1.23 [0.85-1.79],0.2690074608295658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,11750,70,0.72 [0.29-1.78],0.47474354798585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,11739,71,0.67 [0.42-1.07],0.0917662708480808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,11750,70,0.59 [0.29-1.20],0.146858021961232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,11739,71,1.03 [0.38-2.78],0.9494605935674258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,11416,69,0.85 [0.50-1.44],0.5555844967997605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,11723,70,1.08 [0.59-1.99],0.7998122952341108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,11186,67,1.34 [0.89-2.01],0.1591703001517289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,11750,70,1.15 [0.90-1.47],0.2534853650856695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,11739,71,1.00 [0.47-2.13],0.9976247959107052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,13553,85,0.89 [0.52-1.53],0.6656422923119356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,11739,71,0.99 [0.71-1.39],0.9706022319784028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,13545,86,1.14 [0.56-2.32],0.7221358681789203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,13527,85,1.04 [0.79-1.37],0.7788127416357424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,11469,67,0.93 [0.76-1.14],0.5024458185246037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,13448,84,0.95 [0.64-1.40],0.7828342488432293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,11487,69,1.08 [0.78-1.49],0.6394593637771159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,13485,85,0.95 [0.63-1.42],0.7982271173867357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,11676,70,1.07 [0.86-1.33],0.533587006518442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,11723,70,0.90 [0.65-1.26],0.5504155190278786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,13496,84,1.23 [0.87-1.75],0.2363371446847987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",11661,71,0.80 [0.46-1.39],0.4277457751413009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,13241,84,1.14 [0.75-1.73],0.5433063913920426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,13241,84,1.19 [0.88-1.60],0.2535033934553782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,11487,69,0.98 [0.53-1.80],0.9401458269902948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,11469,67,0.90 [0.68-1.19],0.4614037823372069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,11316,67,0.98 [0.71-1.35],0.8957937853095095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,11705,70,0.95 [0.74-1.22],0.6720972411083916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,11723,70,1.15 [0.91-1.46],0.2474188027954535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,13534,81,1.06 [0.88-1.28],0.523848828321908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,11396,68,0.98 [0.71-1.35],0.9028546694188524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,11396,68,1.09 [0.62-1.92],0.7657932715604828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,13208,80,0.99 [0.62-1.58],0.9580960931493888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,11378,66,0.81 [0.56-1.16],0.2447306983770379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,11378,66,0.88 [0.49-1.57],0.6649543997870684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,11396,68,0.97 [0.67-1.41],0.8723684581119484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,13286,80,1.08 [0.64-1.80],0.7812443357134808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,11378,66,1.37 [0.99-1.88],0.0550375876313633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,13553,85,1.04 [0.68-1.58],0.8683022498882662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,13485,85,0.92 [0.65-1.30],0.6302948163516173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,13563,86,1.02 [0.57-1.83],0.953379117628326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,11396,68,0.76 [0.48-1.21],0.2518072031524054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,13286,80,1.10 [0.76-1.59],0.6270281073223308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,11626,71,0.84 [0.50-1.39],0.4860426951651618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,13466,84,1.19 [0.81-1.77],0.3709526705873959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,13466,84,1.68 [0.89-3.15],0.1086142447192171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,11739,71,0.95 [0.39-2.27],0.9002966636333976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,11742,71,1.10 [0.48-2.51],0.8184631237039437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,11723,70,1.13 [0.81-1.57],0.4620511750738999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,11416,69,0.93 [0.74-1.17],0.530495169630957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,11378,66,0.84 [0.62-1.13],0.2497443738832058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,13208,80,0.63 [0.41-0.97],0.037226765304789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,11316,67,0.63 [0.30-1.34],0.2303753949919454
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,11676,70,1.08 [0.83-1.40],0.5655336193009115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,13241,84,1.14 [0.83-1.56],0.4148089972399715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,13584,86,1.04 [0.80-1.35],0.7807303183187437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,11378,66,0.63 [0.34-1.17],0.1415541719958171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,11378,66,0.55 [0.24-1.24],0.1477277859676878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,11378,66,0.55 [0.26-1.15],0.1122279582402587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,11316,67,1.86 [1.27-2.72],0.0013856681398964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,11378,66,0.99 [0.68-1.44],0.9607831055878856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",11378,66,0.99 [0.63-1.55],0.9500424958982316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",13610,85,0.91 [0.77-1.07],0.2487084611974304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",13208,80,1.03 [0.67-1.59],0.8974273262596353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,13241,84,0.98 [0.61-1.57],0.933615528896872
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,13485,85,1.49 [0.84-2.63],0.1717226022089887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,13179,80,1.11 [0.82-1.48],0.5015666931764915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,11416,69,0.92 [0.67-1.27],0.6009013558646945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,11378,66,0.98 [0.76-1.25],0.841205122544477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,11676,70,0.69 [0.28-1.67],0.4048045402251927
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",11750,70,0.96 [0.24-3.77],0.951974848591976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,13208,80,1.09 [0.83-1.44],0.5221224372404293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,11396,68,1.00 [0.81-1.22],0.968837470091993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,11723,70,0.98 [0.62-1.56],0.9401321160019336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,11705,70,1.13 [0.79-1.61],0.5031521700371705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,13534,81,1.02 [0.84-1.26],0.8157162814197593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,13563,86,1.34 [0.68-2.65],0.3953244366558955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,11723,70,1.16 [0.78-1.71],0.4621530465609413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,13113,80,0.95 [0.73-1.23],0.696413582867219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,11750,70,1.20 [0.68-2.11],0.5340281608233755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,11378,66,0.46 [0.19-1.10],0.0813087878816283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",11416,69,1.09 [0.58-2.05],0.7850014265557539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",13610,85,1.72 [0.86-3.42],0.1236436947155898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",13553,85,1.05 [0.47-2.33],0.91137041289149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,11403,65,0.56 [0.23-1.38],0.206371702121335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,13534,81,1.14 [0.87-1.48],0.3384123597588316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,13444,83,1.11 [0.68-1.81],0.6673134446184666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,11403,65,1.04 [0.65-1.66],0.8846250967432326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,13320,81,1.49 [0.88-2.53],0.1401007265633693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,13241,84,1.07 [0.79-1.44],0.6630285948056951
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,13241,84,1.26 [0.68-2.32],0.4558589950462384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,13534,81,0.96 [0.80-1.15],0.6698560830542044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,11705,70,1.07 [0.79-1.45],0.6682401935727951
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,11399,68,0.84 [0.60-1.18],0.3134323190171139
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,13189,80,0.95 [0.76-1.18],0.6227576768023652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,13553,85,1.53 [0.69-3.37],0.2951048425809867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,13466,84,0.97 [0.55-1.72],0.9200462754363944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",11742,71,0.97 [0.46-2.08],0.9422823100713013
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",11396,68,1.10 [0.75-1.62],0.627539135279394
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,11510,71,1.19 [0.52-2.72],0.6730707030481236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,11676,70,0.78 [0.47-1.29],0.3386347260951916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,11705,70,1.02 [0.81-1.27],0.8771583612452759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",13534,81,0.73 [0.50-1.06],0.0994704790745738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,11403,65,1.12 [0.77-1.63],0.5362868015739193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,11316,67,1.24 [0.92-1.68],0.1569662541757478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,11661,71,1.22 [0.79-1.87],0.3668470608067982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,13534,81,1.02 [0.82-1.26],0.8619379751563834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,11721,71,1.01 [0.77-1.32],0.9416105210770384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,11416,69,1.01 [0.70-1.46],0.9522938759705996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,11316,67,1.25 [0.84-1.86],0.2767081835897452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,11721,71,0.96 [0.75-1.24],0.7697925079121059
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,13223,84,1.03 [0.88-1.21],0.6707312947267678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,11396,68,0.81 [0.56-1.17],0.2550664429836011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,11378,66,0.81 [0.32-2.02],0.6468292751743778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,13534,81,1.00 [0.75-1.33],0.992395727627838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,13553,85,1.02 [0.83-1.26],0.8235748334629767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,13241,84,0.92 [0.67-1.25],0.5908426621246525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,13714,86,1.03 [0.57-1.86],0.9178870811218246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,11403,65,0.84 [0.42-1.66],0.6079269786725034
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,11396,68,1.04 [0.77-1.40],0.810778939924546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,11705,70,0.84 [0.47-1.50],0.5513215895097059
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,13553,85,1.16 [0.89-1.51],0.2794573985075611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,11469,67,0.80 [0.35-1.83],0.5998636691864432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,13444,83,1.02 [0.66-1.59],0.9230016513301555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,13293,81,1.13 [0.71-1.82],0.6047480147255264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,11469,67,0.53 [0.19-1.51],0.234888740899431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,11742,71,0.75 [0.38-1.49],0.4115261211941687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,11403,65,1.30 [0.80-2.12],0.283800118649286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,13320,81,2.31 [1.01-5.27],0.047912342284063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,11396,68,0.99 [0.65-1.51],0.9608939605941544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,11416,69,1.11 [0.73-1.67],0.6264761737420332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,11009,65,1.12 [0.90-1.39],0.3218106529399501
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,13532,86,1.26 [0.94-1.70],0.1243863716642208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,11722,70,1.11 [0.81-1.51],0.513979414394343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,11582,69,1.02 [0.83-1.26],0.8646417431620567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,11487,69,0.74 [0.33-1.67],0.4752316668735288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,11396,68,0.90 [0.44-1.85],0.770911665172112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,11378,66,1.27 [0.91-1.76],0.158410301270487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,11378,66,0.78 [0.40-1.50],0.4574573210070711
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,13208,80,1.18 [0.76-1.83],0.4516619551668758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,11396,68,0.92 [0.52-1.61],0.7686426936734274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,11723,70,0.82 [0.46-1.48],0.5145954575300873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSG,Basigin,13681,85,0.72 [0.29-1.80],0.4821119178337685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BSND,Barttin,11316,67,0.75 [0.35-1.61],0.4584977115590531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,13681,85,1.73 [0.97-3.10],0.0651806575716462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,13681,85,0.98 [0.69-1.39],0.9138237096289026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,13241,84,1.03 [0.79-1.34],0.820414667002679
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,11750,70,2.08 [0.68-6.34],0.1995094629932728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,11316,67,0.77 [0.53-1.10],0.1461609138543718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,11641,71,0.60 [0.30-1.20],0.1479051934068758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,13610,85,0.96 [0.44-2.07],0.910855934076181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,13534,81,1.31 [0.78-2.18],0.3061740435294102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,11316,67,1.06 [0.61-1.83],0.8440107961046871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,13208,80,1.14 [0.88-1.49],0.3311637470900108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,11378,66,0.50 [0.22-1.12],0.0902688031878785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,13633,84,1.28 [0.56-2.93],0.5588096114247069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",11723,70,0.90 [0.61-1.32],0.5814387214860999
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,11403,65,1.03 [0.60-1.76],0.9262488461223096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,13563,86,0.86 [0.55-1.35],0.515586154343416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,11469,67,1.19 [0.64-2.22],0.5882753570538899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,11723,70,1.21 [0.66-2.22],0.5422964908001222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,11444,67,0.93 [0.58-1.48],0.7557624962433591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,11750,70,0.70 [0.18-2.69],0.5996055949832493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,11730,70,0.70 [0.22-2.22],0.5470319638643024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,11750,70,0.78 [0.26-2.32],0.6493551668439541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2,Complement C2,13545,86,0.89 [0.43-1.80],0.7364431573292414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,13179,80,0.97 [0.61-1.54],0.8907028740905882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,11399,68,1.31 [0.99-1.73],0.0564122487444621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C3,Complement C3,11151,68,0.88 [0.51-1.53],0.6494587917187237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,13584,86,1.18 [0.74-1.86],0.4830456826247499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C5,Complement C5,11750,70,0.68 [0.14-3.21],0.6270309593996816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,11476,67,1.35 [0.65-2.82],0.4242444767487333
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,11705,70,0.79 [0.28-2.23],0.6497319857267442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,11750,70,1.82 [0.86-3.82],0.1148926319590923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,11739,71,0.80 [0.52-1.23],0.3094850934837521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,11676,70,1.17 [0.90-1.51],0.2399939872457165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,13202,83,1.16 [0.86-1.57],0.3272577973480897
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,13241,84,0.76 [0.38-1.53],0.4424322149803267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,13485,85,1.69 [1.03-2.77],0.0388051424767022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,13389,81,0.94 [0.78-1.12],0.4719003380959292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,13675,85,1.62 [0.92-2.84],0.0940394749813498
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,13511,85,1.15 [0.88-1.48],0.3033228811310274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,13689,86,0.91 [0.67-1.24],0.5585189473262819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,13714,86,0.52 [0.23-1.16],0.1095069339609802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",13320,81,0.88 [0.70-1.09],0.2409853356475159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,13514,85,1.14 [0.84-1.56],0.3928893890706937
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,11487,69,0.83 [0.40-1.71],0.6172600297597737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,11403,65,1.26 [0.58-2.75],0.5640672059307339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,13675,85,1.03 [0.67-1.57],0.9083039751111714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,11399,68,1.14 [0.83-1.57],0.4324104748011662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,11396,68,0.99 [0.49-2.00],0.9733961298868672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,11378,66,1.03 [0.72-1.48],0.856619306809061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,11396,68,0.99 [0.67-1.46],0.9569785803165446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,11723,70,0.93 [0.71-1.21],0.5681594257730365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,11440,67,0.98 [0.78-1.22],0.8298957445679997
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,11399,68,1.18 [0.78-1.79],0.4274552345600049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,13485,85,1.19 [0.74-1.93],0.4686877352987996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,13208,80,1.23 [0.66-2.29],0.5141509648232527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,13437,84,1.13 [0.82-1.57],0.4480989132228562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,11705,70,0.60 [0.30-1.18],0.1400613728585831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,13634,85,1.10 [0.91-1.32],0.3327336945483614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,11416,69,0.92 [0.69-1.25],0.6043559985968112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,11378,66,0.51 [0.23-1.13],0.0991521746211964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,13241,84,1.35 [0.92-1.98],0.1304023001328675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,11399,68,1.49 [1.08-2.05],0.0147925163792804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,11723,70,1.04 [0.84-1.28],0.7409926644703715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,13519,82,0.98 [0.38-2.55],0.965817382322834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,13467,84,1.08 [0.78-1.49],0.6376511855969939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,11661,71,1.04 [0.57-1.91],0.8958238562374189
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,11705,70,0.93 [0.69-1.23],0.5969156157825388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,13208,80,1.04 [0.72-1.50],0.8394463655591178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,11399,68,0.68 [0.38-1.22],0.193328761376834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,13208,80,0.97 [0.72-1.31],0.8291790348959145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,13208,80,0.93 [0.71-1.22],0.6011096266059954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,13534,81,0.95 [0.71-1.27],0.7283623516472568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,13714,86,0.99 [0.80-1.23],0.9572033778458768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,11487,69,0.97 [0.85-1.12],0.7019173181888039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,11705,70,0.95 [0.73-1.25],0.7261582160763167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,13638,85,1.09 [0.81-1.46],0.5830887069884961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,11403,65,1.02 [0.71-1.47],0.9062641866250196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,11378,66,1.37 [1.00-1.87],0.0471554362597591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CAT,Catalase,11553,71,1.20 [0.81-1.77],0.3637664892547518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,13533,82,1.11 [0.84-1.48],0.4598631065303915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,11396,68,0.93 [0.71-1.20],0.5626321055600279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,13675,85,1.68 [1.05-2.69],0.030457451605175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,11416,69,0.82 [0.51-1.33],0.4249084377366307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,11378,66,0.69 [0.34-1.44],0.327716973928552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,13466,84,1.01 [0.78-1.30],0.9682371444964976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,11705,70,0.89 [0.57-1.40],0.619712291398056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,11661,71,1.06 [0.68-1.66],0.8044859612137886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,11399,68,0.91 [0.41-1.99],0.8041822922756611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,11723,70,0.86 [0.62-1.19],0.3691849310946268
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,13551,82,1.22 [0.68-2.21],0.5026950714801054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,11416,69,0.94 [0.64-1.37],0.7327713408478265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,13708,85,1.43 [0.87-2.33],0.1571595771878264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,13687,85,1.11 [0.85-1.45],0.4465731402545949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,13474,86,1.11 [0.69-1.79],0.6621876074200457
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,13714,86,1.12 [0.73-1.72],0.6037912994289925
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,13714,86,0.98 [0.69-1.41],0.9250966252185118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,13522,84,1.19 [0.96-1.46],0.1101742557108526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,13323,86,0.92 [0.69-1.22],0.5489637940676826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,13681,85,1.00 [0.86-1.17],0.963563690655468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,13444,83,1.19 [0.83-1.69],0.3450288941440955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,13708,85,0.92 [0.73-1.15],0.4573008207501629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,13610,85,1.07 [0.70-1.65],0.7438915567409068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,13398,84,0.95 [0.65-1.38],0.7865781373415419
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,13610,85,0.96 [0.60-1.52],0.851176703850814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,13589,85,1.08 [0.86-1.35],0.5120872333276927
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,13708,85,0.73 [0.50-1.08],0.1118493791802502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,13534,81,1.16 [0.96-1.39],0.1243115186836008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,13551,82,1.16 [0.85-1.60],0.3538849410457299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,13494,81,1.17 [0.85-1.61],0.3331675684284935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,13534,81,1.07 [0.81-1.40],0.6433469898549256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,13560,85,1.17 [0.92-1.50],0.2083306227516392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,13563,86,0.94 [0.78-1.13],0.4912020407345716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,13534,81,1.04 [0.76-1.41],0.8199950968977368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,13659,85,1.03 [0.75-1.41],0.8750363650083268
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,13466,85,1.20 [0.94-1.54],0.1512136572391735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,13553,85,1.00 [0.72-1.38],0.986678538702056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,13697,86,1.15 [0.65-2.03],0.6335954670168791
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,13675,85,1.22 [0.79-1.91],0.3723563378761045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,13553,85,1.20 [0.75-1.93],0.4525404544610739
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,11487,69,1.82 [0.96-3.46],0.0654363041333084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,11403,65,0.94 [0.71-1.23],0.6401857086114723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,13466,84,1.13 [0.77-1.67],0.5317168676020959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,13241,84,1.22 [0.84-1.77],0.2986561488448531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,11676,70,1.21 [0.69-2.13],0.4987162794858329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,13553,85,1.65 [0.94-2.90],0.0828465747589895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,13212,85,0.93 [0.58-1.48],0.7509619814594429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,13708,85,0.87 [0.57-1.34],0.5297398845010448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,13563,86,1.49 [0.99-2.24],0.0566925263266414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,13553,85,1.31 [0.68-2.52],0.4274042163994835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,11399,68,1.09 [0.61-1.93],0.7813363951297562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,13533,85,0.91 [0.80-1.05],0.1860954678770289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,13584,86,1.15 [0.50-2.67],0.7391595958498347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,11378,66,0.49 [0.22-1.09],0.0812592202453233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,13534,81,0.74 [0.34-1.59],0.4359804656467249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,13496,80,1.33 [0.75-2.34],0.3300570109013619
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,13271,84,0.96 [0.58-1.61],0.8816929765008471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,13570,85,1.56 [0.96-2.56],0.075169637317497
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,13708,85,1.25 [0.77-2.01],0.3694707658912891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,11403,65,1.54 [0.89-2.68],0.1247734403060301
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,13708,85,1.04 [0.52-2.08],0.9197823940060476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,11721,71,1.30 [0.75-2.27],0.3494148801011117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,13584,86,0.55 [0.33-0.92],0.0227730428656736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,13466,84,0.87 [0.48-1.58],0.6485148297041796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,13547,84,1.09 [0.64-1.87],0.7520169130012921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,13241,84,1.45 [0.87-2.43],0.1553980132505577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,13551,82,1.26 [0.94-1.68],0.1270693127060249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,11469,67,0.90 [0.40-2.00],0.7884653904343291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,13681,85,1.06 [0.61-1.86],0.8324891175723008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,13630,84,1.12 [0.68-1.84],0.6617385544888146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,13675,85,1.10 [0.80-1.51],0.5584430006841409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,13553,85,0.80 [0.48-1.35],0.4102774465648604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,13485,85,1.35 [0.71-2.58],0.3635878221263086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,13584,86,1.21 [0.94-1.56],0.1369391206122157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,13623,85,0.76 [0.34-1.66],0.4851204102416372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,11403,65,1.44 [0.87-2.39],0.1613000360866473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,13485,85,1.60 [0.87-2.95],0.1319496489678835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,11396,68,0.69 [0.32-1.50],0.3479072536917594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,11487,69,0.89 [0.44-1.78],0.7385226407542612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,11403,65,1.23 [1.02-1.47],0.0270884611630099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,13510,81,1.30 [0.73-2.31],0.3801809282372567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,13539,85,0.92 [0.63-1.35],0.6837553335177504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,13708,85,1.07 [0.84-1.37],0.576346935239475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,13419,85,0.97 [0.49-1.92],0.9240998054301576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,13589,85,0.81 [0.42-1.57],0.5395045946851915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,13659,85,0.81 [0.45-1.46],0.4766821690483112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,13041,83,1.44 [0.72-2.86],0.3005064300734543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,13519,84,1.81 [0.60-5.44],0.2900367286139574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,13027,83,0.99 [0.38-2.61],0.989946150993996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,11683,70,1.23 [0.76-1.99],0.3978169153044431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,13681,85,1.02 [0.72-1.45],0.9046328170501092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,13444,83,1.15 [0.80-1.67],0.4533490246637303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,13480,82,0.96 [0.77-1.19],0.7060010596788527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,11383,65,1.00 [0.57-1.77],0.9944243745337332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,13534,81,0.77 [0.48-1.22],0.2617220868966731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,11469,67,0.62 [0.34-1.11],0.1048321010294665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,13681,85,1.17 [0.67-2.04],0.5725045732895477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,13708,85,0.73 [0.45-1.17],0.1927420915273899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,11742,71,1.12 [0.59-2.14],0.726738704272469
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,11487,69,0.95 [0.53-1.69],0.8570615223580416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,13534,81,0.94 [0.51-1.72],0.8401338936184966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,13534,81,0.81 [0.43-1.53],0.5231542608592366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,11676,70,2.10 [1.02-4.31],0.0435585448380047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,13681,85,0.97 [0.66-1.45],0.9000696715937134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,12998,84,1.01 [0.54-1.89],0.9828387581910648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,13553,85,1.10 [0.40-3.00],0.856669173769649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,13553,85,0.70 [0.31-1.57],0.3912656097029771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,11721,71,1.27 [0.82-1.97],0.2826429477555441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,11705,70,1.13 [0.43-2.98],0.7977011423978919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,11316,67,0.88 [0.59-1.33],0.5496252619590332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,11316,67,1.24 [0.76-2.03],0.3794683737325446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,11662,70,0.90 [0.65-1.25],0.5343308051263311
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,13241,84,1.04 [0.76-1.42],0.8235965075167955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,13584,86,0.99 [0.79-1.24],0.9549157877650944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,11676,70,1.01 [0.81-1.26],0.9566041855970095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,13466,84,1.01 [0.68-1.50],0.9461284941866032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,13044,82,0.70 [0.40-1.22],0.2124162485824675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,13652,85,1.42 [0.99-2.05],0.0582646385283269
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,13551,82,1.02 [0.76-1.37],0.888547002426377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,13551,82,1.17 [0.68-2.03],0.576228754306779
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,11487,69,1.05 [0.47-2.35],0.9013315757931132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,11705,70,0.97 [0.41-2.29],0.9413564736957556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,13681,85,1.76 [1.06-2.92],0.0279796984292026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,11396,68,0.68 [0.39-1.19],0.1756650742939578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,13714,86,0.61 [0.32-1.17],0.1397438084855225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,13551,82,1.21 [0.74-1.97],0.4538181466338454
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,13208,80,0.90 [0.55-1.47],0.6769585139453322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,13485,85,0.95 [0.74-1.21],0.6667858483649405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,13551,82,1.06 [0.63-1.79],0.8144401386971838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,11316,67,0.92 [0.49-1.74],0.7974249873590173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,11723,70,0.99 [0.68-1.45],0.9629204464879866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,11396,68,0.69 [0.41-1.17],0.1695477735705614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,13485,85,1.02 [0.85-1.22],0.8586538237093089
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,13485,85,0.95 [0.79-1.16],0.6407652377266303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,13485,85,0.64 [0.34-1.22],0.1748765463231086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,13572,84,1.74 [0.85-3.58],0.1290054015096478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,13664,85,1.03 [0.66-1.61],0.8908680085007352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,13561,85,0.99 [0.46-2.15],0.981178076409838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,11676,70,1.09 [0.82-1.46],0.5579070619532014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,11487,69,1.17 [0.90-1.53],0.2420473402363849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,11676,70,1.34 [0.77-2.36],0.3016946144155993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,11487,69,0.91 [0.53-1.57],0.7430025397294682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,13534,81,0.87 [0.69-1.11],0.2674499629510591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,13241,84,1.26 [0.87-1.81],0.2160601538927119
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,13040,83,1.15 [0.84-1.58],0.3815658780851966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,11721,71,1.26 [0.70-2.28],0.4343838468560965
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,13320,81,1.19 [0.81-1.75],0.3787242599639495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,11403,65,0.94 [0.50-1.77],0.8499152478836078
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,13320,81,1.31 [0.84-2.05],0.2376493903515234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,11721,71,0.99 [0.68-1.44],0.9563358930755368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,13692,86,1.07 [0.77-1.50],0.6839727326511178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11469,67,2.26 [1.03-4.98],0.0430614481903219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,11403,65,0.55 [0.22-1.35],0.1929190606390929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,11396,68,1.04 [0.72-1.50],0.8536176063343106
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,11487,69,1.35 [0.93-1.95],0.1193652929159527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,11487,69,1.23 [0.96-1.58],0.1090323219470211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,11378,66,0.87 [0.49-1.53],0.619186980393357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,11316,67,1.38 [0.95-2.01],0.0897243941295752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,13286,80,0.89 [0.63-1.27],0.5269518836011504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,11416,69,0.86 [0.63-1.17],0.3328732182977952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,13241,84,0.96 [0.74-1.25],0.7890571929504464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,11487,69,0.99 [0.63-1.53],0.9473864639557849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,11316,67,0.92 [0.48-1.76],0.7992555082635971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,13212,81,1.22 [0.92-1.61],0.1698743681659945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,13241,84,1.06 [0.79-1.43],0.6984798920296647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,13208,80,0.95 [0.69-1.30],0.7320166342257698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,13570,85,1.14 [0.92-1.41],0.2409911778780136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,13485,85,1.17 [0.83-1.65],0.3613449329868713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,13485,85,1.21 [0.94-1.56],0.1384613080806113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,13208,80,0.86 [0.63-1.16],0.3224408854279962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,11676,70,0.91 [0.68-1.22],0.5393889243170716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,11521,69,0.70 [0.35-1.41],0.319571648586131
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,13241,84,0.93 [0.61-1.42],0.7357067763777196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,11750,70,0.89 [0.26-3.05],0.8508554223330276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,11065,68,1.17 [0.43-3.16],0.7620810248572281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,11668,69,1.20 [0.78-1.84],0.4166924687442271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,11733,70,0.91 [0.67-1.24],0.5501535164678293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,11590,71,0.88 [0.51-1.51],0.6454691816054741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,11750,70,0.82 [0.26-2.53],0.7286898051828283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CFP,Properdin,11750,70,0.92 [0.33-2.57],0.8683977489314039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,13553,85,0.94 [0.76-1.17],0.5841059068844746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,11739,71,0.83 [0.47-1.47],0.5256537315785785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,11399,68,0.80 [0.42-1.52],0.4959631938844356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,13551,82,1.14 [0.71-1.83],0.5874362491984533
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,13241,84,1.14 [0.84-1.53],0.3976127866319462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,11469,67,0.64 [0.41-0.98],0.0415470805204218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",11705,70,1.16 [0.65-2.09],0.6176342888316944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,11661,71,0.75 [0.32-1.76],0.5054167280459094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,13320,81,1.34 [0.79-2.26],0.2798952039750573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,11721,71,0.75 [0.55-1.01],0.062309498816735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,13624,85,1.19 [0.73-1.93],0.494684573702055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,13189,83,0.95 [0.72-1.25],0.7184723210316546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,13598,86,0.98 [0.87-1.11],0.758463168329977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,13538,86,1.31 [0.75-2.29],0.3503346339908459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,11399,68,0.85 [0.58-1.26],0.432591134292109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,13466,84,0.95 [0.75-1.22],0.7089416432511986
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,11742,71,0.86 [0.57-1.28],0.4498064459660067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,11396,68,0.94 [0.67-1.32],0.7155035882917705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,13589,85,1.66 [0.89-3.12],0.1137301311037185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,13551,82,1.71 [1.29-2.27],0.0001887597839252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,11399,68,0.69 [0.33-1.43],0.31968128760226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,13584,86,0.99 [0.74-1.33],0.9483684229511176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,11721,71,1.20 [0.78-1.84],0.4020835833055345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,11487,69,1.13 [0.71-1.81],0.5993658886911761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,11676,70,0.97 [0.77-1.22],0.7891122194743256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,11399,68,1.12 [0.69-1.80],0.649145614281615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,13631,85,0.83 [0.38-1.83],0.6469496803390133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,11721,71,0.73 [0.50-1.05],0.0924101940025084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",13486,85,0.96 [0.74-1.26],0.7792899583281944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,11316,67,0.99 [0.71-1.38],0.9356470443872256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,13533,82,0.98 [0.73-1.31],0.8797200743547074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,13466,84,1.08 [0.63-1.85],0.7877498968994708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,13524,85,1.05 [0.70-1.58],0.8023932266922426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,11403,65,1.08 [0.32-3.66],0.9044044040194398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,13553,85,1.06 [0.57-1.97],0.8629874856434187
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,13320,81,1.24 [0.66-2.31],0.5043337926318658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,13681,85,0.97 [0.80-1.17],0.7346019489050923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,11399,68,1.05 [0.68-1.62],0.8366863757665159
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,11473,69,0.54 [0.18-1.60],0.2633973667743656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,13534,81,0.95 [0.54-1.67],0.8645761614280012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,13534,81,1.05 [0.68-1.60],0.8317519776865652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,13534,81,0.98 [0.71-1.35],0.9090139324503554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,13534,81,1.13 [0.63-2.04],0.6834379688142653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,11695,71,1.40 [0.87-2.25],0.1601640198569082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,13501,82,0.97 [0.48-1.97],0.929074042449816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,13241,84,0.88 [0.58-1.35],0.5653436325166213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,13708,85,1.13 [0.77-1.64],0.5364304483474329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,11399,68,1.11 [0.67-1.83],0.6960321929159822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,11399,68,0.92 [0.43-1.96],0.8234550140582364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,11316,67,0.78 [0.43-1.41],0.4087689735783828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,13534,81,0.97 [0.82-1.15],0.7367627123426983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,13675,85,1.20 [0.46-3.14],0.7142819448954736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,11399,68,0.76 [0.37-1.57],0.4577851931399292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",13437,84,0.98 [0.80-1.19],0.8359291808243935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,13532,85,0.84 [0.64-1.11],0.2166533768540481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,13179,80,1.00 [0.56-1.81],0.9871436059162556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,13208,80,1.06 [0.73-1.53],0.7714913361654874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,13708,85,1.39 [0.91-2.12],0.1331414873649435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,11705,70,1.32 [0.66-2.60],0.4308140947475272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,13320,81,1.07 [0.70-1.62],0.7607235789260055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,11750,70,1.21 [0.69-2.13],0.5103881515982283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,13535,82,1.02 [0.67-1.56],0.9203869414525108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,11742,71,0.90 [0.70-1.15],0.4012945394551029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,11661,71,0.94 [0.72-1.24],0.6585100818216778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,13563,86,1.27 [0.82-1.96],0.2880531423370362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,11396,68,0.93 [0.60-1.46],0.7637357239258316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",11392,69,0.92 [0.69-1.23],0.5642076850689801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,13320,81,1.15 [0.87-1.53],0.3337248535680756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,13485,85,0.90 [0.70-1.16],0.4274409033128229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNST,Consortin,13551,82,0.95 [0.79-1.13],0.545907220764788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,11396,68,1.18 [0.61-2.26],0.6247177457367248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,13714,86,1.64 [0.82-3.30],0.1629193143815455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,13675,85,1.05 [0.69-1.61],0.8194410076406902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,13553,85,1.31 [0.76-2.28],0.3289488673582867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,13553,85,1.62 [0.74-3.55],0.2290376018993299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,13586,85,1.41 [0.84-2.35],0.1915783025761275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,13534,81,1.01 [0.62-1.65],0.9558963135927144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,11399,68,1.02 [0.82-1.27],0.870403814710487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,11742,71,0.97 [0.60-1.56],0.8881724641519477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,11721,71,0.62 [0.26-1.51],0.2942794553455883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,13597,86,0.68 [0.30-1.54],0.358723755181391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,13714,86,0.65 [0.30-1.41],0.2753986540678641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,11676,70,0.96 [0.65-1.43],0.8465055831802135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,11399,68,0.84 [0.61-1.15],0.2685874871360015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,11416,69,0.85 [0.64-1.14],0.2747676966575788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,11721,71,0.61 [0.23-1.62],0.3221925867413552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,13551,82,0.83 [0.51-1.35],0.4546670158883561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,11470,69,1.13 [0.72-1.78],0.5908364440773423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,11469,67,0.77 [0.42-1.41],0.4004283250955727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,13714,86,1.75 [1.00-3.05],0.0499982468706652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,13534,81,0.83 [0.54-1.30],0.4199868191623299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,11487,69,1.02 [0.64-1.63],0.937697112549507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,13547,84,1.12 [0.51-2.45],0.7840376717331476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,11416,69,0.93 [0.64-1.35],0.7106590873972165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,11661,71,1.14 [0.67-1.97],0.6255640001474865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,13378,86,0.97 [0.56-1.70],0.9227601482314608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,13170,80,1.07 [0.85-1.35],0.5822485560475945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',11378,66,0.96 [0.55-1.66],0.8775929919844067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,13208,80,1.27 [0.93-1.75],0.1383965259704405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",11416,69,0.75 [0.43-1.32],0.3149249380532519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,13260,84,1.03 [0.83-1.27],0.8158568812758386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,11396,68,0.65 [0.32-1.34],0.2479526535747135
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",13485,85,0.95 [0.72-1.25],0.6994097080779781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,11742,71,0.75 [0.36-1.52],0.4213621990769782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,13714,86,0.90 [0.65-1.24],0.5147639649699933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,13628,85,0.82 [0.60-1.11],0.1906567159479489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,11230,67,0.74 [0.43-1.25],0.2586173355033315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,13714,86,1.05 [0.75-1.46],0.7928917415097473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,11723,70,1.02 [0.37-2.81],0.9661070672757224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,13587,85,0.66 [0.43-1.01],0.0584558884696563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,11316,67,0.68 [0.29-1.60],0.3766897629939317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,13622,85,1.67 [1.01-2.76],0.047365440205821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",11403,65,0.75 [0.31-1.82],0.5226703092205609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,13681,85,1.12 [0.85-1.48],0.4276856679058722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,11701,71,1.05 [0.58-1.89],0.8752192270891384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,11378,66,0.87 [0.48-1.58],0.6513030931250814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,13656,85,1.01 [0.62-1.62],0.982776763905267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,13584,86,1.17 [0.90-1.53],0.2503155659451577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,11742,71,1.69 [0.69-4.11],0.2483659915008431
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,11688,71,2.11 [1.15-3.87],0.016148236118769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,13563,86,1.19 [0.78-1.80],0.4177041525132635
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,13241,84,1.04 [0.83-1.29],0.7516172062116271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,13437,84,0.95 [0.74-1.21],0.6649298446510592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,11316,67,1.09 [0.74-1.60],0.6530793484528261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,11316,67,0.76 [0.30-1.95],0.5655179397291186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,13358,85,0.85 [0.49-1.45],0.5488410408096397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,11469,67,1.03 [0.56-1.90],0.9123880271327274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,13589,85,1.06 [0.74-1.50],0.7657015244368788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,13217,84,0.94 [0.75-1.18],0.6019832428226382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,13547,84,0.83 [0.42-1.63],0.5937750967420904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,13320,81,1.17 [0.89-1.54],0.2477154822929383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,13610,85,1.32 [0.51-3.41],0.5605745561292252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,13466,84,1.33 [0.82-2.18],0.2478995401914357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,13675,85,1.11 [0.80-1.53],0.5280524016079701
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,11625,71,1.02 [0.44-2.35],0.9686021197885742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,13561,85,1.00 [0.84-1.19],0.9792892289024172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,13610,85,1.54 [0.74-3.21],0.250733150700406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,13133,84,1.23 [0.91-1.65],0.176752413516748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,13714,86,0.74 [0.40-1.39],0.3486191185371133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,13466,84,0.92 [0.62-1.37],0.6980426396817804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,11399,68,1.13 [0.74-1.72],0.5841519869090581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,13320,81,1.01 [0.85-1.21],0.9061018351440586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,11742,71,0.89 [0.63-1.26],0.5151993165597748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,11705,70,1.28 [0.99-1.65],0.0573428579733412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,11705,70,1.04 [0.82-1.31],0.7677328476566263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,11396,68,1.05 [0.79-1.41],0.7230056906822158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,11416,69,0.94 [0.73-1.20],0.6227215664126676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,11378,66,0.97 [0.79-1.19],0.7482359499914464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,13610,85,0.72 [0.35-1.48],0.3735597463856072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,11739,71,1.60 [0.96-2.67],0.0742550755732657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,11378,66,0.90 [0.47-1.73],0.7476020652022862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,13466,84,0.83 [0.60-1.15],0.2628539108976956
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,11403,65,0.83 [0.49-1.39],0.4744362820257194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,13286,80,0.72 [0.47-1.09],0.1214364631446776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,11403,65,1.19 [0.58-2.42],0.6362907460279352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,11739,71,0.72 [0.33-1.57],0.4101137938381382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,11403,65,0.92 [0.62-1.35],0.6662590228230456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,11723,70,0.93 [0.56-1.54],0.7782166756669906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,11721,71,1.61 [0.82-3.18],0.1657941318199421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,11396,68,1.00 [0.63-1.58],0.9985611518762556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,11378,66,0.98 [0.75-1.26],0.8520550327696408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,10154,60,1.00 [0.77-1.29],0.981402933477496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,13543,85,1.42 [0.71-2.86],0.3250205150028366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,13327,83,1.09 [0.76-1.56],0.653989127048191
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,13210,84,1.92 [1.27-2.90],0.0018836828042103
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,13560,85,0.95 [0.77-1.18],0.6506912524916854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,13353,83,1.10 [0.69-1.76],0.6786407193748929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,11461,69,0.84 [0.52-1.35],0.4698863533451465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,11568,71,1.59 [0.68-3.74],0.2850749642589743
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,13320,81,0.94 [0.74-1.19],0.5862297945031176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,11721,71,1.15 [0.50-2.61],0.743782605454878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,11721,71,0.81 [0.37-1.77],0.6047935331409462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,11396,68,1.40 [0.87-2.26],0.1608332039723092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,13553,85,0.88 [0.62-1.26],0.4985730241464476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,13547,84,1.14 [0.84-1.54],0.3899150183825405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,11705,70,0.69 [0.50-0.95],0.0225380749581111
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,13544,86,0.91 [0.63-1.33],0.6389907164500976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,13521,85,1.30 [0.84-2.00],0.2365999062001628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,12589,82,0.94 [0.57-1.56],0.8229099789883474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,11469,67,1.00 [0.65-1.55],0.9837018146491971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,13584,86,0.67 [0.42-1.08],0.0993958087425985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,13281,81,0.89 [0.67-1.17],0.396022798911615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,13551,82,1.25 [0.55-2.82],0.5988077507610472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,13708,85,1.27 [0.69-2.36],0.4405026679557243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,10705,70,0.74 [0.28-1.94],0.5354555113350812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,13642,85,1.41 [0.95-2.11],0.0892187725574125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,13504,85,1.00 [0.54-1.85],0.9939403450515056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,11399,68,0.46 [0.20-1.04],0.0609510362400141
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,11612,70,1.07 [0.76-1.49],0.7092122040263766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,13466,84,1.17 [0.67-2.02],0.5812046902150494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,13534,81,0.88 [0.59-1.31],0.5326137272119605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,13510,85,0.99 [0.81-1.20],0.8874177496267349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,13610,85,0.99 [0.74-1.31],0.9217920797281788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,13681,85,0.89 [0.70-1.14],0.3754258607252551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,13286,80,1.13 [0.70-1.82],0.6188206583188862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,13681,85,1.10 [0.82-1.48],0.5116224458678814
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,13286,80,1.06 [0.81-1.39],0.6704985828796692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,13684,86,1.01 [0.45-2.27],0.9780437706741164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,13708,85,0.87 [0.55-1.40],0.5730939230007932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,13539,85,0.94 [0.77-1.15],0.5466024295877283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,13504,82,0.94 [0.80-1.11],0.47078152539649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,13708,85,0.91 [0.72-1.16],0.4568483865109535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,13440,84,1.03 [0.78-1.36],0.8150756556092347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,13610,85,0.76 [0.55-1.05],0.0995455166056211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,11316,67,0.87 [0.63-1.22],0.4287436957632549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,11527,70,0.93 [0.62-1.39],0.7217883410209771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",11378,66,0.84 [0.60-1.16],0.2849637965377015
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,11316,67,0.99 [0.72-1.35],0.9508098315482492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,11721,71,0.62 [0.23-1.67],0.3458150300913646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,11469,67,1.00 [0.76-1.33],0.9891714340510472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,13675,85,0.97 [0.82-1.14],0.698553905006772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,13610,85,1.04 [0.70-1.53],0.8521378577397918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,11403,65,1.00 [0.65-1.54],0.989007353576165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,11403,65,1.25 [0.87-1.80],0.2184898710339224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,13534,81,0.97 [0.83-1.14],0.7038626845205365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",13437,84,1.07 [0.83-1.39],0.6015650110621943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,11718,71,1.07 [0.85-1.34],0.5718080499974001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,13491,85,1.01 [0.79-1.29],0.9206072749531218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,11403,65,1.15 [0.74-1.77],0.533931902533417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,13610,85,0.98 [0.80-1.20],0.8654522358137606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",13584,86,0.66 [0.39-1.12],0.126243853931901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,11399,68,1.18 [0.46-3.05],0.7320483951161215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,11316,67,1.22 [0.92-1.62],0.1737580586145801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,11316,67,1.12 [0.55-2.26],0.7578815664304557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCN,Decorin,13320,81,1.73 [0.72-4.15],0.2225302387918608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,11469,67,0.96 [0.75-1.22],0.7256136380782957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,13675,85,1.18 [0.89-1.57],0.2609907267482718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,13485,85,1.09 [0.89-1.33],0.3979084765158538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,13208,80,0.95 [0.71-1.28],0.7561195680524204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,13551,82,1.11 [0.60-2.08],0.7368641012486695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,11396,68,1.07 [0.81-1.41],0.6443189052636316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,11316,67,1.24 [0.98-1.56],0.0732779766362958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,13584,86,1.10 [0.78-1.55],0.583324098896997
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,11378,66,0.59 [0.29-1.19],0.1399043735652479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",13485,85,0.87 [0.57-1.35],0.5384987944791464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,13533,82,0.89 [0.60-1.32],0.5720925869442506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,11723,70,1.06 [0.76-1.49],0.7337431436213449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,11469,67,1.06 [0.80-1.41],0.6823464634644367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,13681,85,1.87 [0.86-4.07],0.116904653637562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,11721,71,1.07 [0.63-1.82],0.8036868050775365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,11676,70,0.79 [0.48-1.29],0.3418672249111601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,11399,68,0.56 [0.27-1.18],0.1292919629462336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,11403,65,1.70 [0.65-4.47],0.2830429815201983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,11403,65,0.91 [0.57-1.44],0.6862452109721283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,11399,68,0.64 [0.32-1.26],0.19610736119295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,13241,84,0.99 [0.72-1.37],0.9633753557532324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",13534,81,0.89 [0.73-1.08],0.2423133490358433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,13235,84,0.82 [0.55-1.24],0.3476227395061896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,11317,63,1.23 [0.78-1.93],0.3706844898451278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,11396,68,1.17 [0.82-1.65],0.3835792004301155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,11396,68,1.02 [0.76-1.37],0.9043068948262668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,11396,68,0.75 [0.44-1.27],0.2780483421311813
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,13353,83,1.15 [1.02-1.31],0.0266829887103195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,11378,66,1.00 [0.65-1.55],0.992086668938017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,11403,65,0.96 [0.64-1.47],0.8671192371272178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,13708,85,1.05 [0.80-1.38],0.7388019462353297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,11396,68,0.98 [0.57-1.67],0.9335013318555184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,11403,65,0.94 [0.61-1.46],0.7805141171425224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,13286,80,0.82 [0.46-1.45],0.4940527375006006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,11378,66,0.99 [0.60-1.62],0.9571118859499494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,11661,71,0.84 [0.46-1.51],0.5570177776110584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,11705,70,0.68 [0.39-1.18],0.1719705963688941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",13501,82,0.90 [0.75-1.07],0.224157730406087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,11399,68,1.05 [0.62-1.79],0.8533353618121249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,11469,67,0.55 [0.23-1.32],0.1796980365869173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,13681,85,1.19 [0.87-1.62],0.2680807616625572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,13714,86,1.35 [0.71-2.58],0.3598668365630739
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,13443,84,1.22 [0.81-1.82],0.3427203489527607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,13485,85,0.95 [0.76-1.18],0.6376841479709214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,11705,70,0.91 [0.65-1.26],0.55256201091752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,11723,70,0.95 [0.62-1.47],0.834558365990242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,13714,86,0.96 [0.68-1.36],0.8302253309592144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,13584,86,0.90 [0.46-1.77],0.7611036313196771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,11416,69,0.94 [0.68-1.29],0.6956237040104006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,11416,69,0.86 [0.52-1.40],0.538493047761138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,11416,69,0.79 [0.58-1.09],0.1588686108804856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,11316,67,1.03 [0.64-1.65],0.9066519625672012
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,13658,85,1.02 [0.82-1.29],0.8335622344799681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,11705,70,1.02 [0.75-1.38],0.889070614949441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,13485,85,1.03 [0.83-1.28],0.7719938679816232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,11676,70,0.94 [0.67-1.33],0.7350288257391624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,11469,67,1.02 [0.67-1.56],0.9217596179447372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,11352,67,0.97 [0.74-1.27],0.8137680880738265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,13320,81,1.28 [0.98-1.67],0.0675382979885477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,11705,70,1.29 [0.75-2.22],0.3632871085155137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,11416,69,1.05 [0.80-1.38],0.7094715351658092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,11676,70,1.07 [0.80-1.43],0.6657172221445264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,13526,84,1.14 [0.53-2.47],0.7399800386755943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,11396,68,0.92 [0.70-1.22],0.5642792247066795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,11676,70,0.95 [0.78-1.16],0.6257276509547314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,11723,70,0.90 [0.59-1.38],0.6281795230620858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,13466,84,1.07 [0.79-1.45],0.6431110750319919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,11705,70,0.93 [0.64-1.35],0.6925929742452719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,13582,85,1.23 [0.86-1.75],0.2561276551861886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,11399,68,1.12 [0.64-1.97],0.6871659217930783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,11396,68,1.16 [0.99-1.36],0.0674747968744302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,11705,70,0.99 [0.84-1.17],0.9266668269306512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,13551,82,0.99 [0.84-1.16],0.8689474566087076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,13437,84,1.37 [0.92-2.03],0.1177236174966365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,13485,85,0.43 [0.22-0.84],0.0131436720279794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,13534,81,0.85 [0.47-1.51],0.5716019116180266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,13243,85,1.36 [0.72-2.59],0.3421629632657825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,13485,85,0.91 [0.51-1.61],0.7360012863156243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,13435,81,1.05 [0.76-1.46],0.7754934654970442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,13714,86,0.66 [0.34-1.31],0.2353180283819235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,13634,84,0.99 [0.72-1.37],0.964739504246822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,13466,84,1.25 [0.80-1.94],0.3281900818619291
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,13485,85,0.95 [0.68-1.34],0.7870416424856161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,13404,85,1.08 [0.60-1.93],0.8003501300294433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,11723,70,0.63 [0.33-1.19],0.1549007575228133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,13553,85,0.95 [0.47-1.90],0.8781603171945281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,13635,84,1.20 [0.68-2.14],0.5298959497078194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,13431,85,1.15 [0.79-1.67],0.4593405576203088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,11469,67,0.90 [0.69-1.17],0.4190069307337927
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,11647,71,1.05 [0.63-1.76],0.8418054279804854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,11399,68,0.92 [0.64-1.31],0.6457547284498727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,13485,85,0.95 [0.42-2.14],0.9051171925637332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,11742,71,1.00 [0.73-1.38],0.9829568917156442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,13320,81,1.13 [0.89-1.43],0.3099218345669003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,11661,71,1.34 [0.82-2.17],0.2411407093987854
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,11399,68,1.17 [0.88-1.57],0.2783041899456363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,13208,80,0.88 [0.68-1.13],0.314545334056862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",11676,70,0.96 [0.77-1.20],0.7322141329615821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,11705,70,1.06 [0.65-1.72],0.822780736991602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,11661,71,1.16 [0.79-1.72],0.453291976670209
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,11399,68,1.25 [0.99-1.59],0.0662074405622606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,11661,71,1.21 [0.74-1.96],0.4516841261244881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,13466,84,1.02 [0.84-1.25],0.8295874688170657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,13654,85,1.44 [0.80-2.61],0.2261135867731115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,13208,80,1.09 [0.62-1.91],0.7707164018810388
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",11742,71,0.95 [0.71-1.28],0.7364945337037742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",11416,69,0.91 [0.72-1.15],0.4228995570998912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,11378,66,0.90 [0.61-1.34],0.6202593751394241
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,11405,69,0.97 [0.52-1.81],0.9207402820947636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,11396,68,1.20 [0.82-1.76],0.339271995910406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,13675,85,1.29 [0.72-2.32],0.3892420337441464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,13534,81,0.89 [0.72-1.10],0.2938016391152963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,11661,71,0.75 [0.43-1.32],0.3209896743395415
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,11378,66,0.71 [0.34-1.48],0.3590359745561104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,11723,70,0.95 [0.68-1.32],0.7571346283263192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,13320,81,0.97 [0.55-1.72],0.9200209509521676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,11416,69,0.98 [0.44-2.22],0.9669406323656944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,11403,65,0.89 [0.50-1.56],0.6754761475551134
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,11742,71,1.05 [0.83-1.34],0.6853887487153545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,11676,70,1.16 [0.51-2.64],0.7213911502658005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,11487,69,1.02 [0.54-1.93],0.9600300773410324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,13533,86,0.68 [0.36-1.28],0.2263913014636384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,11723,70,1.19 [0.65-2.16],0.5750329198699804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,13530,85,0.84 [0.40-1.77],0.6529041568763674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,13444,83,1.32 [0.66-2.65],0.4356960056771907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,11399,68,0.84 [0.56-1.27],0.4084375324721395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,13521,84,0.98 [0.82-1.18],0.8326951424426035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,13241,84,1.47 [0.96-2.26],0.077727370909733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,11676,70,1.24 [0.63-2.43],0.533448968567945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,13714,86,0.72 [0.22-2.36],0.5847040787311714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,13534,81,1.05 [0.75-1.46],0.7910424767758806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,11742,71,0.93 [0.69-1.26],0.6491263039762324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,11416,69,0.90 [0.74-1.09],0.2741529683028335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",11705,70,0.98 [0.65-1.50],0.941257176922154
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",11644,69,1.01 [0.82-1.24],0.9169314497081276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,11378,66,0.94 [0.65-1.35],0.7294455711154304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,11416,69,0.85 [0.47-1.53],0.5860105719947262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,13466,84,1.02 [0.74-1.41],0.9056644766569936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,11403,65,1.01 [0.78-1.31],0.937513643741126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,13551,82,1.20 [0.91-1.60],0.1995033384329417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,13708,85,1.06 [0.87-1.28],0.5653220344064875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,11723,70,0.84 [0.59-1.21],0.3481610814108234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,11378,66,0.92 [0.53-1.59],0.7555222692774667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,13286,80,1.27 [0.69-2.32],0.4455618952199569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,11723,70,0.95 [0.73-1.24],0.7234796078778274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,11396,68,0.95 [0.73-1.24],0.692840693386011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELN,Elastin,11742,71,1.45 [0.75-2.78],0.2688657886604962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,13485,85,0.98 [0.68-1.40],0.8931750998488164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,11378,66,0.83 [0.45-1.55],0.5661999130498325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,13286,80,1.09 [0.74-1.62],0.6654209726405633
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,10855,61,1.08 [0.66-1.75],0.7692545926793577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,13714,86,1.43 [0.47-4.37],0.52955133023622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,13528,84,0.92 [0.72-1.17],0.4960527821928918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,13681,85,0.96 [0.72-1.28],0.7781893846533365
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,11416,69,1.40 [1.00-1.96],0.0486164228095557
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,11661,71,1.00 [0.67-1.49],0.9931859030147152
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,11378,66,0.54 [0.22-1.36],0.1922545026949983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,11378,66,0.76 [0.39-1.47],0.419631590008793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,13714,86,0.68 [0.35-1.32],0.2539546079820641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,13610,85,1.45 [0.86-2.45],0.168162376004218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,11416,69,0.84 [0.45-1.58],0.5942596743298125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,13156,81,1.08 [0.87-1.34],0.5026485382813664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,11661,71,0.64 [0.39-1.02],0.0625887880552121
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,13241,84,0.96 [0.62-1.47],0.8435679417893722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,13320,81,2.14 [0.82-5.58],0.1215827989346863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,13320,81,1.81 [0.80-4.11],0.156101112544424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,11416,69,1.27 [0.89-1.79],0.1862940513190866
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,11403,65,0.76 [0.34-1.71],0.5083754605128631
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,11399,68,1.12 [0.81-1.55],0.5097895805211132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,13550,84,0.81 [0.66-1.00],0.047124080135289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,11661,71,1.34 [0.98-1.83],0.0645828678150998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,13582,85,1.25 [0.71-2.20],0.44357199587705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,13208,80,1.08 [0.81-1.43],0.6229897077971824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,13071,84,0.52 [0.26-1.05],0.0682678963967023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,11469,67,0.69 [0.30-1.59],0.379703996117136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,13714,86,0.90 [0.40-2.03],0.8072489562793825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,13437,84,1.36 [0.73-2.56],0.333070280734439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,13320,81,1.26 [0.98-1.62],0.0759856270300687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,11487,69,1.16 [0.74-1.82],0.5188547240237114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,13534,81,1.37 [1.14-1.65],0.0007980603453746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,11416,69,0.84 [0.61-1.15],0.2680955696794406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,13655,84,0.91 [0.47-1.75],0.7774484900430827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,13584,86,2.61 [1.23-5.51],0.0120648117081729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,13494,84,1.78 [0.67-4.75],0.2502826418860963
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,13584,86,1.50 [0.68-3.33],0.3139925293575452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,13485,85,0.97 [0.80-1.16],0.7067371076159424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,11399,68,1.02 [0.77-1.36],0.8656504110585744
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,11316,67,1.19 [0.65-2.18],0.5741390804561713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,13437,84,0.95 [0.74-1.21],0.66922989100532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,11487,69,1.18 [0.62-2.24],0.6122294667774466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,11403,65,1.36 [0.81-2.27],0.2394076647300011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,11661,71,1.56 [0.97-2.51],0.0681210703161621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,11469,67,0.94 [0.77-1.14],0.5221564995547785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,13466,85,0.76 [0.36-1.60],0.4737331812712292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,11378,66,0.69 [0.39-1.24],0.2151848714099561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,13714,86,0.88 [0.48-1.61],0.6773004957872385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,13547,84,1.63 [0.93-2.85],0.0856720441148628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,11316,67,1.13 [0.79-1.61],0.5101282433886064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,11403,65,0.94 [0.62-1.44],0.7821073262099172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,11705,70,0.99 [0.75-1.30],0.9240456118705076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,11316,67,0.88 [0.48-1.63],0.6873431193454325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,11403,65,0.98 [0.75-1.27],0.8502435888999382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,11487,69,0.68 [0.30-1.53],0.3508864785642958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,11378,66,0.79 [0.50-1.24],0.3079651296650553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,11378,66,1.00 [0.63-1.61],0.9885736611957252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,13681,85,0.85 [0.38-1.90],0.696879687424439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,11739,71,0.63 [0.26-1.53],0.3094319990077643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,11579,69,0.82 [0.37-1.85],0.6375978288290585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,13553,85,0.98 [0.70-1.37],0.9142322130071032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,11750,70,1.00 [0.58-1.71],0.9899825321673597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,11683,70,1.41 [0.58-3.42],0.4465080965687885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,11750,70,1.41 [0.30-6.56],0.6645314999972004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,13589,85,0.97 [0.70-1.34],0.8379881277733667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,13589,85,0.56 [0.28-1.12],0.1021760825631323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,13543,86,0.63 [0.34-1.18],0.1459043150343393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,13545,86,1.78 [0.61-5.18],0.2878645750034697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",13547,84,1.00 [0.81-1.23],0.9717982454606062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",13551,82,0.82 [0.63-1.07],0.1358122070212494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",11742,71,1.17 [0.73-1.87],0.522435577804599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",13714,86,1.01 [0.69-1.49],0.9487563635586884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,13645,85,1.10 [0.84-1.45],0.4829993110573461
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,13303,81,0.85 [0.58-1.25],0.420161399456108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,13534,81,1.32 [0.94-1.84],0.1063268114521892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,13551,82,0.98 [0.76-1.26],0.8579916202141179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,11676,70,0.96 [0.69-1.36],0.8367014888500959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,11723,70,1.00 [0.87-1.15],0.9901896719639784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,11661,71,0.86 [0.37-2.00],0.7336210664416831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,11416,69,0.87 [0.60-1.26],0.4499254838464926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,11742,71,1.26 [0.58-2.75],0.5543411291425875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,13485,85,0.79 [0.48-1.30],0.3508106043793575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,13533,82,0.93 [0.48-1.81],0.8246097275440047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,11676,70,1.04 [0.79-1.37],0.76170939360163
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,13714,86,2.02 [1.02-4.00],0.0427133238360474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,11399,68,1.11 [0.82-1.52],0.493807958657519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,13664,86,0.89 [0.48-1.65],0.7100824270517848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,13708,85,1.05 [0.63-1.76],0.8551931739211451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,11721,71,1.81 [0.89-3.70],0.1027048848616547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,11399,68,0.79 [0.54-1.15],0.2162705856017834
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",13551,82,1.07 [0.83-1.39],0.5944908137757817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,11742,71,0.79 [0.58-1.08],0.1467413569829591
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,13534,81,1.07 [0.71-1.62],0.7435941815264516
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,11723,70,1.56 [0.61-4.00],0.3517631072426974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,13553,85,0.77 [0.51-1.16],0.213790993768408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,13458,86,1.00 [0.74-1.37],0.9797376473252772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,13241,84,1.14 [0.82-1.59],0.4421986862220617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,13519,86,1.31 [0.88-1.95],0.1823918358685789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,11718,71,1.44 [0.91-2.27],0.1158971864681399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,13457,86,0.72 [0.49-1.08],0.1091408029352915
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,13551,82,0.90 [0.58-1.41],0.6461825956552069
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,13644,84,0.88 [0.57-1.35],0.5548661053828827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,13286,80,0.93 [0.64-1.34],0.6847367782492726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,13553,85,0.87 [0.62-1.23],0.4424125627348224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,13534,81,1.02 [0.76-1.36],0.9199681957128054
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,13241,84,0.93 [0.66-1.32],0.6947978800985959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",11378,66,1.19 [0.86-1.63],0.30018129972581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",11378,66,1.27 [0.91-1.76],0.158332224166908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,13241,84,1.24 [1.00-1.54],0.0460143419377811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,13241,84,1.18 [0.81-1.71],0.3940370817696784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,13545,86,0.99 [0.56-1.73],0.9658700439373424
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,11466,68,0.85 [0.40-1.82],0.6830061510767339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",11723,70,0.96 [0.73-1.28],0.7997405747804645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,11403,65,0.80 [0.43-1.50],0.4961578712380554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,11403,65,0.91 [0.54-1.53],0.7241087076460212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,13610,85,1.05 [0.83-1.35],0.6714761558522274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,13534,81,0.87 [0.65-1.18],0.3792876426703716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,11403,65,0.95 [0.55-1.66],0.8657726364781535
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,13654,85,1.05 [0.89-1.23],0.5524755029136205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,13656,85,1.29 [1.02-1.63],0.0369342527962127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,11403,65,1.60 [1.01-2.53],0.0465514767298615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,13286,80,1.52 [0.87-2.67],0.1437691494519921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,11403,65,1.03 [0.61-1.75],0.9092758531654848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,11316,67,1.14 [0.90-1.45],0.2806045244985924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,11293,67,0.95 [0.53-1.71],0.8742956630035917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,13584,86,0.80 [0.44-1.45],0.4579527804520601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,11721,71,0.77 [0.49-1.23],0.2759040979981214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,11705,70,1.64 [0.90-2.97],0.1055315917776204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,13584,86,1.56 [0.69-3.53],0.2901231900806447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,11469,67,0.69 [0.44-1.07],0.0977371843869821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,11739,71,0.81 [0.57-1.17],0.2614026651390632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,13208,80,1.29 [0.99-1.67],0.0547337656824597
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",11396,68,1.01 [0.78-1.31],0.9121593641124234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,11378,66,0.93 [0.57-1.53],0.782497966654438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,13208,80,0.95 [0.73-1.24],0.7216512002362878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,13532,85,0.97 [0.76-1.24],0.8146326093515107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,11723,70,0.96 [0.77-1.21],0.7288906708555649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,13596,84,1.04 [0.88-1.23],0.6692580537561452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,13466,84,1.06 [0.69-1.62],0.8036505483263822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,13466,84,1.00 [0.82-1.22],0.9843333855044506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,13179,80,0.98 [0.65-1.49],0.9399836384218386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,11676,70,1.03 [0.70-1.50],0.8891717315142778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,13241,84,0.95 [0.80-1.14],0.6123359570912683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,13466,84,1.66 [0.85-3.24],0.1387448341172167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,13457,85,1.02 [0.43-2.42],0.9702643294818948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,13241,84,1.43 [0.92-2.21],0.1130932016063546
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,13708,85,0.99 [0.55-1.78],0.9688826170500076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,13584,86,0.75 [0.43-1.29],0.2980100377379293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,13208,80,1.11 [0.84-1.46],0.4563790073037944
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,13241,84,1.35 [0.79-2.30],0.2675641818266387
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,11750,70,2.14 [0.94-4.87],0.0708995860634271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,11705,70,1.04 [0.64-1.68],0.8805067688019383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,11661,71,1.07 [0.58-1.95],0.8296760432606115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,11403,65,0.86 [0.65-1.13],0.2825589628391361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,13513,85,1.22 [0.60-2.48],0.5780815238440952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,13681,85,0.83 [0.43-1.61],0.5835512103814491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,13538,84,0.95 [0.85-1.06],0.3408256068642855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,11293,67,0.80 [0.41-1.56],0.5174775385240962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,13208,80,0.82 [0.46-1.45],0.4913616962633008
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,11403,65,1.03 [0.61-1.72],0.914174524913676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,13534,81,0.97 [0.77-1.23],0.8255277415110304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,13241,84,1.00 [0.82-1.22],0.9872410212093568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,11378,66,0.94 [0.66-1.33],0.7161608424100312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,11399,68,1.02 [0.52-1.99],0.9637565884400968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,13420,83,1.63 [0.76-3.49],0.2073547752699772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,11416,69,0.90 [0.64-1.27],0.5591223790019666
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FST,Follistatin,13589,85,1.07 [0.74-1.55],0.7121474466970628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,11416,69,1.77 [0.66-4.74],0.2588153202559175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,13526,84,1.28 [0.68-2.40],0.4377284411605729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,11691,70,1.10 [0.86-1.40],0.4593883355698271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,13628,86,1.18 [0.91-1.52],0.2042581542046005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,11469,67,1.00 [0.70-1.42],0.9913702201481804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FURIN,Furin,13584,86,1.63 [0.95-2.81],0.0762252626017433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,13222,84,0.98 [0.60-1.62],0.9496093985044236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",11465,69,1.02 [0.72-1.44],0.9154041345317828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13681,85,1.04 [0.68-1.59],0.8454491530728405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",13466,84,1.02 [0.73-1.41],0.920102515103506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",13675,85,0.98 [0.76-1.26],0.8554923440515384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,13286,80,0.89 [0.65-1.21],0.4522772890443064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,13532,85,0.99 [0.80-1.21],0.8935130665730429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,11399,68,1.21 [0.90-1.63],0.1985275953256921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,11396,68,1.17 [0.73-1.87],0.5192373130389698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,11661,71,1.17 [0.77-1.76],0.4627924637921794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,11487,69,1.12 [0.82-1.52],0.4893018347564486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,11396,68,1.04 [0.75-1.45],0.8052353942428074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,11316,67,0.96 [0.38-2.39],0.9260633682247474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,11403,65,0.82 [0.47-1.44],0.4902371433911935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,11487,69,1.17 [0.80-1.72],0.4072436551644908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,11416,69,0.74 [0.47-1.17],0.196581354731074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,11316,67,0.86 [0.56-1.32],0.4971637397998321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,13610,85,1.62 [1.20-2.18],0.0016011881789325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,13485,85,1.24 [0.64-2.42],0.5227818802146056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,13675,85,1.01 [0.48-2.13],0.9772024561849204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,13286,80,1.53 [0.97-2.42],0.0697956355425805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,11742,71,1.12 [0.48-2.64],0.7873082480576502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,13485,85,0.77 [0.31-1.91],0.5766588342268172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,11378,66,1.17 [0.70-1.97],0.5458983501524873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,11217,67,1.22 [0.58-2.53],0.6028752190309287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,11723,70,0.59 [0.21-1.60],0.2977470943764276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,11487,69,1.28 [0.94-1.75],0.1189547882499792
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,13614,85,1.66 [0.80-3.42],0.1730813761108874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,11378,66,0.66 [0.39-1.13],0.1323783804418335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,11705,70,0.94 [0.78-1.14],0.5422745375859386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,11316,67,1.64 [0.70-3.85],0.2553005263734987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",11416,69,0.76 [0.56-1.03],0.0763415179951153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,11399,68,0.89 [0.58-1.38],0.6046499904478755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,11682,70,0.64 [0.49-0.84],0.0014098372492649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,13286,80,0.87 [0.62-1.22],0.4137122047118372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,13208,80,1.03 [0.69-1.53],0.8891074504914731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,11378,66,0.85 [0.47-1.52],0.5806086633399596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,11750,70,1.63 [0.70-3.77],0.2570556621955426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,11705,70,0.96 [0.78-1.18],0.7129324806952796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,13241,84,1.03 [0.88-1.20],0.7387820438163097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,11180,67,1.03 [0.65-1.64],0.8833653616320698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,11378,66,0.97 [0.57-1.64],0.9028067329257808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",13485,85,1.21 [0.70-2.10],0.4956445478364307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,13714,86,0.82 [0.49-1.35],0.4304058884536299
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,13551,82,1.11 [0.65-1.92],0.7003908401514063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,13208,80,1.66 [1.02-2.70],0.0396191150860496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,11742,71,1.39 [1.03-1.88],0.0305987971136511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,13225,84,0.90 [0.57-1.40],0.6327184861243655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,13241,84,1.02 [0.76-1.37],0.8822274124585459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,13241,84,0.93 [0.79-1.10],0.4217248962211184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,13654,85,1.26 [0.63-2.53],0.5142791319840874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,13485,85,0.97 [0.39-2.40],0.9509128067673354
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,13422,82,0.75 [0.37-1.52],0.429744071310283
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,11357,70,1.01 [0.70-1.45],0.9635673158631518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,13208,80,0.92 [0.68-1.24],0.5760764647332526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,11742,71,0.81 [0.59-1.12],0.2062955722871464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,11721,71,1.03 [0.65-1.65],0.8889000040854617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,13271,84,1.09 [0.62-1.91],0.7716436188344288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,13530,85,1.48 [1.06-2.07],0.020978789564702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,13466,84,1.52 [0.71-3.24],0.2775149440680197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,13533,82,0.98 [0.88-1.09],0.7237328850389636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,13241,84,0.97 [0.86-1.09],0.6136865757952279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,11469,67,1.33 [0.59-3.00],0.4890219071971823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,13208,80,1.10 [0.81-1.49],0.5571719686284871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,13551,82,0.95 [0.74-1.22],0.6958833255829477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,11723,70,1.56 [1.01-2.41],0.0438333393308655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,11723,70,0.99 [0.73-1.32],0.9238408200067056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,11469,67,0.50 [0.22-1.13],0.0971189903665798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,11316,67,0.96 [0.60-1.52],0.8519244066167285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,11416,69,0.45 [0.25-0.80],0.0063892828786795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,11705,70,0.68 [0.30-1.56],0.3678926937568637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,11676,70,1.07 [0.85-1.35],0.5588806269478614
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,11403,65,1.03 [0.63-1.69],0.9045533422001708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,11403,65,1.00 [0.78-1.28],0.9966758756199422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,11316,67,0.88 [0.58-1.33],0.5334917279012559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,12947,77,1.16 [0.56-2.42],0.6902850843195444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,11440,67,1.28 [0.71-2.32],0.4089921825008855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,13466,84,1.12 [0.71-1.77],0.6359700824399328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,11403,65,0.88 [0.42-1.85],0.7349839787996175
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,13320,81,1.05 [0.75-1.46],0.7777952635971515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,13511,85,1.14 [0.68-1.91],0.6159230730895066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,11396,68,0.82 [0.42-1.61],0.5702778071560346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,13474,82,1.22 [0.88-1.69],0.2384226939509705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",11469,67,0.92 [0.71-1.19],0.5237267569810319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,13208,80,0.82 [0.51-1.32],0.4073359671371224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,11661,71,1.00 [0.70-1.43],0.9949450937196818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,11457,71,1.05 [0.58-1.92],0.8634159703090118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,11742,71,0.97 [0.71-1.32],0.8244379160718569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,13708,85,1.01 [0.69-1.46],0.9783131735361092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,11469,67,1.03 [0.73-1.45],0.8837443802273801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,11723,70,0.96 [0.73-1.24],0.7368972550094359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,13241,84,1.04 [0.79-1.37],0.7913784820243812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,11399,68,0.57 [0.31-1.06],0.0768226842199766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,13553,85,1.13 [0.77-1.65],0.5254374698008031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,11416,69,0.96 [0.48-1.93],0.917451628884464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,11469,67,0.99 [0.52-1.88],0.969674599295323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,11723,70,1.25 [0.95-1.63],0.1057920370179573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,13681,85,1.64 [0.73-3.68],0.2280732964419772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,13534,81,0.97 [0.80-1.17],0.7552656852858822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,11676,70,0.96 [0.60-1.56],0.8765633008049257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",11721,71,0.99 [0.58-1.69],0.9579827669868158
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,13463,86,1.03 [0.57-1.88],0.917510987150186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,11378,66,0.86 [0.60-1.22],0.3897472061257465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,13145,79,1.54 [1.30-1.83],1.0130724693847046e-06
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,11469,67,0.82 [0.44-1.53],0.5300119413970237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,13532,85,0.99 [0.80-1.23],0.9361413751225114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,13485,85,0.89 [0.77-1.03],0.1094979060636298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,13675,85,1.03 [0.53-1.98],0.9337741568518276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,13466,84,1.01 [0.72-1.43],0.9338163656866288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,11661,71,1.07 [0.71-1.61],0.76111044048707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,11676,70,1.22 [0.84-1.76],0.2998126514655886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,11739,71,0.93 [0.58-1.49],0.7494574590817695
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,11676,70,1.12 [0.80-1.57],0.506477211680675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,13208,80,1.49 [0.89-2.48],0.1289598504857305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,13191,81,2.19 [1.11-4.32],0.0240314531624049
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,11396,68,0.90 [0.60-1.36],0.6114396242334277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,11723,70,0.93 [0.50-1.75],0.8271998999792611
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,11676,70,1.00 [0.70-1.43],0.9967851367980266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,13320,81,1.13 [0.84-1.53],0.413243030302149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,11661,71,1.01 [0.68-1.49],0.9618808044439728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,13551,82,0.97 [0.83-1.13],0.6833163573753334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,11742,71,1.05 [0.75-1.49],0.7594837804120714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",11723,70,1.14 [0.68-1.90],0.6164406593049236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",11396,68,1.20 [0.88-1.64],0.2521807180511374
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,13320,81,1.21 [0.88-1.67],0.2403270268875471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,13490,85,0.61 [0.27-1.37],0.2296005711821483
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,11416,69,1.18 [0.76-1.83],0.4513599192059571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",13485,85,0.90 [0.65-1.25],0.5391053832223114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,11256,67,0.89 [0.66-1.21],0.4490205698512746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,13241,84,1.22 [1.05-1.41],0.0104941996246429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,11695,71,0.62 [0.20-1.93],0.4092445403207121
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",11665,71,1.54 [0.55-4.30],0.4083530248636565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,13533,82,1.06 [0.85-1.31],0.6067420689889538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,13241,84,1.11 [0.89-1.40],0.3499341564151433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,11378,66,0.94 [0.66-1.34],0.7324189230767288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,13126,80,0.94 [0.70-1.27],0.7015010351878697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,11705,70,1.01 [0.92-1.10],0.9078973975003068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,11487,69,0.86 [0.59-1.25],0.4261503001894615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,11399,68,1.01 [0.76-1.35],0.9486431259909572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,13488,84,1.17 [0.64-2.12],0.6183829175667325
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,11487,69,0.94 [0.71-1.24],0.659674818408319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,11378,66,0.72 [0.36-1.46],0.3618415020164843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,13600,86,1.30 [0.97-1.74],0.0764198872608364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",13320,81,0.99 [0.80-1.22],0.935845418430928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,13708,85,0.76 [0.44-1.31],0.3231504944579147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,13534,81,1.01 [0.74-1.37],0.9695242947285208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,13320,81,0.84 [0.63-1.13],0.2475346963660877
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,11316,67,1.06 [0.67-1.66],0.8099657833964594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",11378,66,1.04 [0.75-1.46],0.8039609000294188
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",13638,85,1.07 [0.83-1.37],0.6048436664912896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,13675,85,1.01 [0.88-1.16],0.8780438911408439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",13553,85,0.97 [0.76-1.23],0.7943339508359618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,13659,85,0.98 [0.71-1.35],0.892131873449396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,13553,85,1.19 [0.68-2.08],0.5487309660984645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,13638,85,1.10 [0.85-1.41],0.4869795674242406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,13675,85,1.06 [0.78-1.45],0.7041502347778547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,11742,71,1.01 [0.81-1.25],0.960171138607697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,11378,66,0.61 [0.32-1.17],0.1363620864704462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,13708,85,1.08 [0.77-1.52],0.665021541710757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,11403,65,0.91 [0.60-1.38],0.6618463539026099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,11396,68,0.74 [0.47-1.17],0.201677178688292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,11676,70,1.04 [0.63-1.73],0.8680254798750444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,13659,85,1.20 [0.99-1.47],0.06476210329827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,11705,70,1.08 [0.77-1.52],0.6677210059225918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,13320,81,1.04 [0.76-1.44],0.7979669417037762
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,11469,67,0.66 [0.28-1.57],0.3476711519931514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,11705,70,1.01 [0.58-1.76],0.962434660033592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,11742,71,1.52 [0.63-3.71],0.3536226612643584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,13534,81,1.06 [0.84-1.35],0.6054247951323435
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,13708,85,1.36 [0.79-2.33],0.2627229208443788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,11627,71,0.71 [0.33-1.53],0.3840161063301001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,13241,84,1.00 [0.78-1.28],0.9847321975493906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,11705,70,1.07 [0.79-1.44],0.658751782771356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,11403,65,0.94 [0.63-1.38],0.7341613928932598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,11378,66,0.74 [0.35-1.58],0.431326553048888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,11688,69,1.00 [0.60-1.67],0.9895259542626448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,11723,70,1.14 [0.70-1.85],0.6040600991672369
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,13320,81,1.37 [0.71-2.67],0.3482180433253226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",11723,70,0.98 [0.49-1.97],0.9630429010274404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",13490,80,1.17 [0.68-2.02],0.5675847251021786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",13534,81,0.89 [0.43-1.84],0.7473790107723847
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,13675,85,1.19 [0.79-1.79],0.4144312999140759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,11446,67,0.88 [0.59-1.32],0.5432265409949011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",11416,69,0.61 [0.37-1.01],0.0538496997529389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",11378,66,0.64 [0.35-1.17],0.1490996976449607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,11302,67,0.80 [0.46-1.40],0.4401991081149532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,13402,82,0.82 [0.53-1.27],0.384366715201778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,13208,80,1.28 [0.89-1.85],0.1784543126494527
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,11399,68,1.28 [1.03-1.59],0.0262070832317379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,13393,83,0.81 [0.53-1.22],0.3071868319353164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,13276,81,1.07 [0.83-1.37],0.6069460296522224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,11723,70,0.93 [0.59-1.49],0.7716288541655216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,13708,85,0.99 [0.77-1.27],0.922406999884741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,13241,84,1.22 [0.76-1.96],0.4068494111703569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,11554,71,1.04 [0.82-1.32],0.770722722716515
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,11471,69,0.95 [0.73-1.23],0.6846645942010182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,11416,69,0.72 [0.35-1.49],0.3714547588563731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,11683,70,0.93 [0.45-1.91],0.8431581412937934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,11416,69,0.92 [0.71-1.19],0.5040852308487495
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,13485,85,1.16 [0.71-1.90],0.558227858429226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,13675,85,0.82 [0.47-1.44],0.4858548230277594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,11403,65,1.57 [0.75-3.26],0.2312092682989422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,11416,69,1.07 [0.84-1.36],0.567671026383627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,13534,81,0.71 [0.44-1.15],0.1645351152212195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,11705,70,1.05 [0.73-1.52],0.7789991215447091
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,11378,66,0.56 [0.32-1.00],0.04844039526638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,11416,69,0.72 [0.44-1.20],0.2074146106264456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,13147,80,1.11 [0.86-1.43],0.4283739367563334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,13582,85,0.99 [0.76-1.29],0.961221359239967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,11661,71,0.80 [0.39-1.65],0.5388585960993377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,13319,82,0.95 [0.72-1.26],0.7198267277896359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,13675,85,1.53 [0.93-2.52],0.0922823482567337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,13403,85,1.52 [0.72-3.21],0.2688549886608313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,11396,68,0.96 [0.71-1.30],0.8017896474769406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,11396,68,0.74 [0.40-1.37],0.333588119164345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",13584,86,0.92 [0.68-1.25],0.6123592448531672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,13426,86,0.55 [0.23-1.27],0.1612930560268606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,13714,86,0.91 [0.37-2.20],0.8284581033128041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,13286,80,1.04 [0.81-1.32],0.7783193780825195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,13464,86,0.97 [0.50-1.88],0.9168637442771906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,13714,86,0.67 [0.36-1.24],0.1995732761465277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,13714,86,0.89 [0.41-1.92],0.7627992728730808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,13534,81,1.03 [0.71-1.49],0.8776244180443425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,13551,82,0.75 [0.48-1.16],0.1915618556425618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,13485,85,0.75 [0.27-2.04],0.5734081758468124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,11487,69,0.76 [0.42-1.36],0.3567702374155278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,13208,80,1.42 [1.01-2.01],0.045174562844491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",11416,69,0.85 [0.58-1.24],0.3863463393405432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,13708,85,2.86 [0.28-29.38],0.3764925966435921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,13675,85,0.98 [0.65-1.48],0.939971674465606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,11400,67,0.92 [0.50-1.70],0.788594538828185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,11487,69,1.34 [0.94-1.92],0.1056036072109926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,11487,69,0.82 [0.43-1.57],0.554154660811917
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,11676,70,1.25 [0.56-2.76],0.5868059028712589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,13286,80,0.94 [0.80-1.12],0.5089453613883923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,13610,85,1.88 [0.74-4.80],0.1840096107708305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,13466,84,1.04 [0.72-1.49],0.8331676876133773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,13208,80,0.84 [0.54-1.31],0.4514016549543596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,11396,68,0.58 [0.34-1.01],0.0522129423576849
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,13534,81,1.36 [0.87-2.13],0.18135250797233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,11378,66,1.03 [0.58-1.85],0.909724401484538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,11399,68,1.06 [0.64-1.77],0.8212655936119324
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,11723,70,1.10 [0.76-1.58],0.6179826952465723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,11396,68,1.15 [0.79-1.68],0.4696707541296658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,11721,71,1.49 [0.62-3.59],0.3688755235923462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,13485,85,0.58 [0.23-1.46],0.2456379483880492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,11378,66,1.17 [0.76-1.78],0.473053793510826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,13553,85,0.97 [0.43-2.17],0.9338720571776382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,13689,86,0.91 [0.78-1.07],0.2573729948073795
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,13686,86,0.82 [0.62-1.09],0.1643441480068977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,13563,86,1.58 [0.78-3.21],0.2058374662301612
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,13364,85,1.13 [0.69-1.85],0.624352400270094
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,13457,86,1.61 [0.83-3.11],0.1554313676282916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,13714,86,1.10 [0.59-2.03],0.7707573074527816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,13551,82,1.06 [0.62-1.82],0.832430520704826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,11403,65,0.91 [0.63-1.30],0.5930605678123433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,11378,66,1.11 [0.75-1.64],0.6010379676043609
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,11731,70,1.34 [0.63-2.85],0.440987114248444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,11316,67,0.88 [0.65-1.20],0.4281494149184366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,11416,69,1.30 [0.84-2.01],0.2380133112542737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,13485,85,1.32 [0.83-2.10],0.2488680628793138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,13551,82,0.80 [0.42-1.52],0.4998359993017769
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,11742,71,0.97 [0.75-1.27],0.8318004245122712
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,13534,81,1.05 [0.85-1.29],0.6688047129610522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,13241,84,0.98 [0.80-1.20],0.8256347814571345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,13286,80,1.04 [0.83-1.31],0.7009585879573001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,13286,80,1.00 [0.72-1.39],0.9996399930776524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,13610,85,1.36 [0.71-2.60],0.3546757652472682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,13286,80,0.93 [0.66-1.31],0.676459681431971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,13485,85,0.85 [0.66-1.09],0.1931180136899554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,13708,85,0.80 [0.56-1.14],0.2094323490179618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,13286,80,0.73 [0.43-1.25],0.2518551476041894
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,11403,65,0.77 [0.42-1.41],0.3985999722131071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,13286,80,0.87 [0.55-1.36],0.539626634592018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,13370,84,1.30 [0.51-3.29],0.5767773074746416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,11396,68,0.63 [0.29-1.41],0.2649799617639672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,13534,81,0.81 [0.44-1.51],0.5095688280970567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,13286,80,1.23 [0.70-2.17],0.4726336883542541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,13708,85,1.17 [0.77-1.78],0.4594688572322981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,13271,80,0.95 [0.57-1.56],0.8260555533259789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,13286,80,0.89 [0.66-1.22],0.4790477996374837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,13286,80,0.83 [0.43-1.60],0.5852681448275789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,13286,80,1.05 [0.84-1.33],0.6544567649383238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,13553,85,1.03 [0.67-1.59],0.8883970764575853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,13355,81,1.02 [0.71-1.46],0.915689024716182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,13498,84,0.69 [0.45-1.07],0.0971372797226919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,13563,86,0.90 [0.47-1.70],0.7362936144375442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,13708,85,1.30 [0.75-2.26],0.3482265917316204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,13379,83,1.00 [0.89-1.11],0.9365627949901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,13212,80,1.52 [1.19-1.94],0.0008243720802422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,13286,80,1.20 [0.89-1.60],0.2282915954016001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,13223,79,1.17 [0.83-1.63],0.3665506716139373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,13530,85,0.80 [0.35-1.84],0.5959561581710675
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,13527,84,1.91 [0.70-5.22],0.2060156788213171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,13553,85,1.80 [1.18-2.74],0.0060161926024867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,13664,86,1.29 [0.85-1.97],0.2287515600054245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,13286,80,1.46 [0.88-2.42],0.1400557149931446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,13511,85,0.96 [0.69-1.33],0.7875037384079038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,13286,80,1.35 [0.70-2.60],0.3631392763085396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,13286,80,1.07 [0.73-1.57],0.718412307252943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,13286,80,1.21 [0.84-1.72],0.3040843458994366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,11403,65,0.86 [0.49-1.50],0.5885219146663055
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,11403,65,0.87 [0.53-1.41],0.5668717177548224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,11661,71,1.25 [0.92-1.70],0.1546909196284045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,13286,80,0.83 [0.50-1.36],0.4515149364265554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,13286,80,0.90 [0.58-1.39],0.6400940065777518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,11275,67,0.88 [0.45-1.73],0.7133029210041264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,13447,85,1.04 [0.64-1.71],0.8708618767335883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,13286,80,0.94 [0.56-1.57],0.8177805827473918
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,11661,71,0.56 [0.27-1.17],0.1242412596562945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,11316,67,1.00 [0.69-1.45],0.9856041728002448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,11403,65,1.15 [0.82-1.61],0.420238069960273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,11361,64,1.02 [0.57-1.84],0.9359034633540404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,13534,81,0.71 [0.44-1.15],0.1640541158977648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,13286,80,1.10 [0.66-1.82],0.7157853799405438
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,13189,80,2.03 [1.15-3.59],0.0145233925768641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,11403,65,0.73 [0.45-1.20],0.2144356670303276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,11361,65,0.85 [0.58-1.26],0.4254192642180975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,13286,80,0.84 [0.44-1.60],0.6050244290261892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,13286,80,0.88 [0.74-1.06],0.1716493868970521
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,13534,81,0.79 [0.45-1.38],0.4033449740875776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,13286,80,1.12 [1.00-1.26],0.0480567234601716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,13534,81,0.91 [0.63-1.30],0.6029530043218458
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,13485,85,1.04 [0.80-1.35],0.7641311350196829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,13435,86,0.92 [0.52-1.60],0.7574677759153369
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,13551,82,1.22 [0.49-3.04],0.6625331199651718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,13534,81,1.07 [0.80-1.44],0.6580533087263958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,13553,85,0.82 [0.57-1.17],0.2728700582765642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,11487,69,1.07 [0.75-1.52],0.6974042680853318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,13192,79,1.11 [0.81-1.52],0.5221318624513505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,11661,71,1.15 [0.72-1.84],0.5470272563785601
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,13466,84,0.86 [0.63-1.18],0.343240148202233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,11705,70,1.20 [0.81-1.78],0.3712907505786582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,11396,68,1.16 [0.57-2.38],0.6753349681501071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,13179,80,1.14 [0.77-1.69],0.5148619346850882
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,11469,67,1.12 [0.71-1.77],0.625686280740787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,13553,85,1.86 [1.15-3.00],0.0112021203675954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,13485,85,0.98 [0.69-1.40],0.9196407363931218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",11416,69,1.09 [0.73-1.63],0.6685463170737752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",11723,70,1.22 [0.78-1.89],0.3826454722542962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",13485,85,1.00 [0.82-1.21],0.96225455403218
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,11705,70,0.65 [0.48-0.89],0.006056367780128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,11661,71,0.83 [0.50-1.38],0.4769840264790428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,11676,70,1.02 [0.80-1.29],0.890338918371259
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,11403,65,1.73 [0.43-7.00],0.4402724220250731
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,13444,83,0.88 [0.71-1.09],0.2374283710384974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,13485,85,1.11 [0.78-1.57],0.5665827521419081
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",13320,81,0.99 [0.79-1.24],0.9188623224421076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,13286,80,1.13 [0.86-1.49],0.3734790506308857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,13534,81,0.99 [0.82-1.19],0.8973155080019898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,13014,78,1.14 [0.66-1.95],0.6444189721879277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,13534,81,1.46 [0.93-2.29],0.102437794959096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,11721,71,0.85 [0.48-1.49],0.5658816615231865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,11598,69,1.02 [0.81-1.28],0.8901295523631957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,13534,81,1.01 [0.58-1.76],0.9808832409478372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,11469,67,0.85 [0.42-1.72],0.6537358815364007
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,13553,85,1.38 [0.66-2.90],0.3948308565466178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,13534,81,0.97 [0.68-1.39],0.8785230559952687
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,11403,65,0.94 [0.55-1.62],0.8265823281379996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,13553,85,1.05 [0.58-1.90],0.8781938162674703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,13675,85,1.45 [0.46-4.59],0.5251904758366698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,11487,69,1.04 [0.69-1.57],0.8486369714492837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,13494,86,1.49 [0.64-3.47],0.3585438592324446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,13241,84,0.83 [0.52-1.33],0.4458630111538602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,13320,81,1.00 [0.84-1.19],0.9735179608550278
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,13455,84,0.89 [0.45-1.74],0.7313178991407372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,13584,86,0.96 [0.58-1.58],0.8651066572533265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,13286,80,1.75 [0.90-3.40],0.1015025822474995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,13675,85,1.34 [0.89-2.00],0.1565145453453189
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,11721,71,1.05 [0.57-1.93],0.8685507921250071
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,11750,70,1.09 [0.33-3.53],0.8891448268309802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,13563,86,0.88 [0.53-1.44],0.6001533977103567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,11750,70,0.79 [0.34-1.85],0.5861952761409976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,11661,71,1.23 [0.81-1.89],0.3336882716994486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,13534,81,1.00 [0.71-1.41],0.99256563820816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,11378,66,0.79 [0.55-1.13],0.1941405437807649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",11416,69,1.11 [0.83-1.49],0.4825968440443486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",11396,68,0.77 [0.44-1.34],0.3605227979178652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",13208,80,0.98 [0.66-1.47],0.9382799219391074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,11316,67,1.26 [0.91-1.76],0.1683183335078402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,13681,85,0.82 [0.38-1.77],0.6207071428145874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,11469,67,0.97 [0.62-1.53],0.9076612868325684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,13286,80,0.87 [0.62-1.22],0.4217962900636819
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,11316,67,0.74 [0.45-1.21],0.22655868760095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,11676,70,1.04 [0.80-1.35],0.766173754707411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,13286,80,1.16 [0.85-1.57],0.3467831668986182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,13485,85,1.44 [0.92-2.25],0.1130018153294577
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,11676,70,1.08 [0.87-1.34],0.502935985978863
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,11396,68,0.54 [0.30-0.97],0.0382577743086405
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,11399,68,0.92 [0.66-1.29],0.6414659216084659
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,13208,80,0.74 [0.46-1.20],0.2212987707918118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,11484,69,0.98 [0.58-1.66],0.9492550418537256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,11403,65,0.94 [0.72-1.23],0.6564871432722552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,13584,86,0.56 [0.28-1.14],0.1123472414206625
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,13208,80,1.88 [1.08-3.27],0.0249167080785485
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,11316,67,0.82 [0.54-1.23],0.3310232997367383
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,11416,69,1.03 [0.72-1.45],0.8855705656721172
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,11705,70,0.73 [0.34-1.59],0.4299870045648974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,11487,69,0.96 [0.70-1.34],0.8244180601879216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,11487,69,0.64 [0.27-1.51],0.3063323140879946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,11661,71,1.23 [0.91-1.67],0.1713314377169441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,11378,66,0.72 [0.33-1.54],0.3938053956428058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,11396,68,0.97 [0.72-1.31],0.8321804919060952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,11378,66,1.08 [0.88-1.31],0.4633256614372425
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,13485,85,0.91 [0.73-1.14],0.3968422718894171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,11661,71,0.92 [0.71-1.21],0.5582103745692766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,13241,84,1.01 [0.78-1.30],0.9560065187093638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,11676,70,1.07 [0.94-1.22],0.3194147318489212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,13241,84,1.00 [0.85-1.18],0.968579514375935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,11316,67,0.96 [0.72-1.28],0.7817917716952856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,11396,68,1.17 [0.88-1.54],0.2819731310119727
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,13208,80,1.10 [0.67-1.78],0.7116446967346581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,13545,86,0.84 [0.44-1.60],0.5933082426245442
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,13551,82,1.09 [0.64-1.86],0.7490019416992826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,13208,80,0.91 [0.69-1.20],0.5137137084691996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,11396,68,0.90 [0.50-1.64],0.7394919264048556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,11723,70,1.26 [0.84-1.88],0.2643102762196475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,13408,85,1.12 [0.97-1.29],0.1199609825616363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,13546,86,1.22 [0.76-1.95],0.4142853029054173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,13445,85,0.98 [0.50-1.90],0.9472999139794164
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,13241,84,1.02 [0.89-1.17],0.766085700054457
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,13249,84,1.02 [0.65-1.60],0.9217922066570934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,13675,85,0.80 [0.53-1.21],0.2918164544105537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,11645,71,1.56 [1.02-2.39],0.0405002914489033
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,11721,71,0.60 [0.41-0.87],0.0070885198399358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,13675,85,1.56 [1.20-2.02],0.0007576643381523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,13572,85,1.72 [0.90-3.30],0.1020765210039538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,11139,67,0.61 [0.33-1.13],0.1140443175539352
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,13084,80,1.06 [0.60-1.88],0.8313995721097649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,11522,68,1.51 [0.61-3.72],0.3683472653126076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,13708,85,1.07 [0.64-1.79],0.8017179634298207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,11396,68,0.86 [0.56-1.32],0.4935489594980266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,13708,85,0.95 [0.62-1.44],0.8040188702718476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,11403,65,0.92 [0.52-1.61],0.767115334996136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,11705,70,1.05 [0.63-1.74],0.8607816105159356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",12776,76,0.85 [0.40-1.82],0.6830519288508337
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",11378,66,0.87 [0.46-1.64],0.6589056783540689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",13485,85,1.06 [0.84-1.32],0.6393876074618745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",13518,81,0.88 [0.65-1.21],0.4301202852808433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",13208,80,1.01 [0.67-1.52],0.968322283784178
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",11378,66,0.60 [0.29-1.26],0.1776323676437276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",11396,68,0.69 [0.44-1.10],0.1185097188164587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,13521,82,1.07 [0.77-1.50],0.6808814404611302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,13708,85,0.91 [0.60-1.38],0.672399107427827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,13584,86,0.82 [0.42-1.61],0.5597111052136361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,11742,71,0.78 [0.61-1.01],0.0596489666353564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,11645,71,0.96 [0.60-1.55],0.8734612887000719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,13551,82,0.99 [0.74-1.32],0.9316540207902672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,13485,85,1.04 [0.65-1.66],0.8830230809291548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,13547,84,0.93 [0.54-1.60],0.7826528588693002
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,13466,84,0.94 [0.78-1.12],0.4840591723019343
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,11378,66,1.07 [0.71-1.61],0.7400126394927447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,13610,85,0.88 [0.50-1.53],0.643582735394087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,11416,69,0.94 [0.45-1.98],0.8762328886765133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,11412,70,1.51 [0.95-2.42],0.0840582146229373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,13137,81,2.10 [0.72-6.13],0.1763240381689945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,13681,85,0.96 [0.65-1.41],0.8353164395638344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,11661,71,1.09 [0.65-1.82],0.74748413069108
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,13286,80,1.11 [0.76-1.64],0.5814121082636484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,11661,71,1.14 [0.83-1.55],0.4174416792274636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,13708,85,1.02 [0.80-1.30],0.893560020217627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,13485,85,0.98 [0.84-1.15],0.8249312770263463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,11403,65,1.05 [0.80-1.38],0.7374166594178806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,13437,84,0.87 [0.48-1.59],0.6554287952045547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,13563,86,0.79 [0.57-1.08],0.1434446312809751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,13681,85,1.02 [0.78-1.33],0.906023791774562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,11739,71,1.36 [0.49-3.77],0.5594431777326867
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,11723,70,0.85 [0.58-1.26],0.4304810467048067
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,13083,82,0.91 [0.52-1.59],0.7399899473861791
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,11721,71,1.07 [0.68-1.70],0.7689967985067607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,13589,85,0.89 [0.62-1.29],0.5474033483714824
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,11723,70,1.02 [0.81-1.29],0.8389981727115704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,11742,71,1.01 [0.71-1.43],0.9762523216913616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,13654,85,1.44 [1.03-2.01],0.0329621168075083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,11070,64,0.93 [0.66-1.31],0.6678558260338506
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,11396,68,1.16 [0.89-1.51],0.2709841467059798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,11723,70,1.34 [0.75-2.41],0.3228446694693959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEP,Leptin,13551,82,0.95 [0.70-1.30],0.7667996484435342
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,13551,82,1.01 [0.53-1.89],0.9874249577476756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,11723,70,0.92 [0.59-1.42],0.7027892565032566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,13551,82,0.82 [0.45-1.50],0.5201409695627954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,13584,85,1.02 [0.53-1.95],0.9541366971587072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,11750,70,1.19 [0.60-2.36],0.621477483287799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,13547,84,0.58 [0.40-0.86],0.0063928918742353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,13539,84,1.26 [0.81-1.96],0.3147705411660074
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,13681,85,0.80 [0.58-1.11],0.174495621004816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,13539,85,0.76 [0.41-1.40],0.3766431303849056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,13610,85,1.19 [0.71-2.00],0.5017270114949155
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,13241,84,1.06 [0.87-1.30],0.5613131489582479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,13561,85,1.07 [0.78-1.47],0.6822635118997264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,13208,80,0.85 [0.57-1.28],0.442432509939589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,13534,81,0.95 [0.42-2.13],0.8934246836079576
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,13553,85,0.87 [0.52-1.45],0.5932320020282775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,11721,71,1.01 [0.85-1.19],0.9432802478782392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,11378,66,0.63 [0.36-1.11],0.1097811336339056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,13533,82,1.03 [0.55-1.91],0.9354919126326018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,11742,71,0.94 [0.69-1.26],0.6620419265639677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,13714,86,1.31 [0.66-2.60],0.432959759077871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,13636,86,0.81 [0.47-1.39],0.4430886272102627
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,13286,80,1.11 [0.70-1.77],0.6479386646774156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,13714,86,0.89 [0.69-1.16],0.4023638960977292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,11416,69,1.24 [0.86-1.78],0.258726583088651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,11651,70,1.28 [0.96-1.71],0.0923149612177481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,11705,70,1.06 [0.47-2.38],0.8876027388277884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,11723,70,1.47 [0.90-2.40],0.1193878192502411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,11396,68,0.87 [0.59-1.28],0.4738509273797888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",11416,69,0.86 [0.66-1.13],0.2800462750788641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),11446,68,1.13 [0.99-1.30],0.0679348433193236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,13485,85,1.07 [0.71-1.62],0.7451947366040053
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,13551,82,0.74 [0.51-1.08],0.1210214629697063
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,13139,81,1.01 [0.73-1.40],0.9568924167919534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,11378,66,0.94 [0.66-1.34],0.743131853708072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,11378,66,1.05 [0.74-1.48],0.7878009941263973
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,11399,68,1.11 [0.74-1.67],0.6120687963354075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,11750,70,0.73 [0.31-1.73],0.4708651272841985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,13638,85,0.65 [0.37-1.13],0.1266831383337039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,11360,65,1.00 [0.46-2.20],0.994951195680196
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,13485,85,1.13 [0.54-2.36],0.737279399724083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,13551,82,1.21 [0.69-2.12],0.5021457987215956
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,11399,68,1.28 [0.73-2.25],0.3936789523569578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,11399,68,0.91 [0.67-1.23],0.5263583216301229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,13681,85,0.86 [0.58-1.25],0.4215219881016957
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,13485,85,1.23 [0.78-1.91],0.3717941076148793
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,11676,70,0.87 [0.51-1.49],0.6061459056602644
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,11399,68,1.42 [1.02-1.98],0.03764703851682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,11742,71,0.92 [0.57-1.50],0.7420606070146505
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,11661,71,1.16 [0.74-1.82],0.5135681142340323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,13286,80,1.30 [0.78-2.19],0.3168471613703095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,11399,68,0.80 [0.43-1.49],0.4845935469959292
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,11723,70,1.27 [0.59-2.71],0.5408434054051738
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,13241,84,0.91 [0.63-1.31],0.6087729070700538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,11487,69,1.05 [0.83-1.34],0.6894228951960157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,13534,81,1.53 [0.98-2.39],0.0619419143292229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,13534,81,0.77 [0.47-1.27],0.3123731965609689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,13675,85,0.87 [0.62-1.22],0.4116138693890943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,11661,71,0.55 [0.26-1.17],0.1235250310271014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,13714,86,1.54 [0.85-2.80],0.1532191568242444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,13241,84,1.28 [0.97-1.68],0.0812997041026445
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,13469,84,1.38 [0.68-2.80],0.3688257615884335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,13286,80,0.67 [0.39-1.17],0.1609877442636943
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,11661,71,1.02 [0.63-1.66],0.9218296800009368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LXN,Latexin,13401,84,1.11 [0.85-1.46],0.4433262207435768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,13462,84,1.33 [0.79-2.26],0.2814774512469039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,13534,81,0.65 [0.40-1.06],0.0854127282327946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,13426,83,1.51 [0.76-3.00],0.2372032679771876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,13466,84,1.26 [0.73-2.17],0.4054956794896922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,13241,84,0.99 [0.68-1.42],0.944028917364125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,13485,85,0.87 [0.70-1.08],0.2113844024663674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,13208,80,1.15 [0.89-1.49],0.2777031654445764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,13480,85,1.48 [0.86-2.52],0.1540266079201047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,13241,84,0.91 [0.62-1.34],0.6473164858917109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,11396,68,1.11 [0.92-1.33],0.2688435639612752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,11399,68,1.26 [1.04-1.51],0.0153742600056206
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,11750,70,2.03 [0.66-6.25],0.2174630680135636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,11316,67,0.82 [0.41-1.63],0.5641990020088617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,11469,67,0.96 [0.69-1.33],0.8075686905834031
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,11416,69,1.18 [0.73-1.89],0.4990649134782018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,13419,83,1.07 [0.73-1.55],0.7403196205887705
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,13241,84,0.92 [0.56-1.52],0.7471482368418909
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,11399,68,0.99 [0.61-1.62],0.9685115655309042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,11487,69,0.92 [0.71-1.20],0.546503472312775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,13241,84,1.06 [0.71-1.58],0.7644563722926181
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,11742,71,0.93 [0.47-1.84],0.8346211158807022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,11661,71,1.11 [0.74-1.67],0.6058667315865789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",11416,69,0.57 [0.23-1.41],0.2256560911022663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,11742,71,1.27 [0.87-1.86],0.212868833210345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",11316,67,1.06 [0.68-1.66],0.8044918224186748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,13610,85,1.01 [0.86-1.18],0.9384136712030156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,13584,86,1.49 [0.74-3.00],0.2595249352342542
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,11378,66,0.86 [0.58-1.27],0.4399383523313602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,11396,68,0.78 [0.37-1.62],0.5007254475532319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,11378,66,0.92 [0.62-1.37],0.684935890090212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,11705,70,1.09 [0.68-1.76],0.7212725618461585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,11676,70,0.96 [0.68-1.36],0.8183730365153258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,13534,81,0.99 [0.82-1.20],0.9337051704942116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,13241,84,1.07 [0.88-1.30],0.4832473083472655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,13437,84,1.01 [0.85-1.20],0.9268670007826588
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,11316,67,1.10 [0.68-1.78],0.6964630713855837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,13534,81,0.93 [0.59-1.46],0.7442274541580036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,11487,69,1.17 [0.87-1.59],0.2986686951947307
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,11316,67,1.03 [0.88-1.20],0.7482727676415851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,13208,80,0.97 [0.67-1.41],0.878339182925788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,13551,82,1.38 [0.65-2.90],0.4004972079989028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",11440,67,0.96 [0.73-1.26],0.7800565687654741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,13437,84,1.22 [0.54-2.73],0.6331768768227379
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,13572,84,1.73 [0.93-3.20],0.0842609993146402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,13444,83,1.00 [0.54-1.86],0.9985786798760156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,13241,84,1.03 [0.84-1.27],0.7497609936974585
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MAX,Protein max,13208,80,1.01 [0.83-1.22],0.9388412195060142
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,13714,86,0.98 [0.67-1.45],0.9344176046243692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,11576,69,0.96 [0.77-1.18],0.687207746655023
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,13563,86,1.06 [0.61-1.83],0.8418258304834236
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",11723,70,0.96 [0.57-1.63],0.8864127397793174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,11403,65,0.91 [0.70-1.19],0.4960862178345803
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,13503,82,0.94 [0.61-1.46],0.7884945181915162
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,11676,70,0.89 [0.36-2.25],0.8119147761482837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,13466,84,0.98 [0.75-1.28],0.8965267456410922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",11665,71,0.91 [0.52-1.59],0.7438392334681077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDK,Midkine,13543,86,0.72 [0.49-1.07],0.1089861697310902
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,11399,68,1.08 [0.52-2.25],0.8383085079537904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",11416,69,0.84 [0.66-1.09],0.1872180925449215
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,13241,84,0.97 [0.76-1.25],0.8351987532995561
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,11378,66,1.39 [1.00-1.92],0.0476707586250991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,13547,84,1.35 [0.82-2.22],0.231188361255331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,11378,66,0.80 [0.37-1.77],0.5871333769342693
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,13664,86,0.63 [0.25-1.58],0.3237376909949106
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,11742,71,1.09 [0.52-2.28],0.8161307687259113
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,11469,67,0.67 [0.24-1.85],0.4406771191830373
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,11676,70,0.81 [0.58-1.14],0.2284742189679992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,13551,82,1.06 [0.90-1.25],0.4903773228223129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,13547,84,1.69 [0.77-3.71],0.194680754047233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,13708,85,0.54 [0.26-1.14],0.1076438595462605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,13553,85,0.99 [0.85-1.15],0.8835476337140508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,13584,85,0.44 [0.17-1.15],0.093453270417005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,13208,80,0.86 [0.44-1.70],0.6631131267642825
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",13534,81,0.89 [0.70-1.13],0.3299924477421045
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,13654,85,1.16 [0.83-1.61],0.3902197569585554
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,13320,81,1.46 [1.13-1.89],0.0036644205936341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,11399,68,1.00 [0.71-1.39],0.9817224571899456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,11469,67,1.18 [0.57-2.45],0.6483283507229989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,13714,86,1.69 [1.07-2.69],0.0254922889769491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,13553,85,1.03 [0.66-1.60],0.8943075576202362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,13589,85,1.01 [0.81-1.25],0.946450900067835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,13534,81,0.99 [0.85-1.16],0.9354600762493284
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,13584,86,1.23 [0.73-2.07],0.4396120481035518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,11399,68,1.01 [0.72-1.43],0.952621317941036
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,13534,81,0.91 [0.81-1.01],0.0883445344883689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,13532,85,1.07 [0.81-1.41],0.62366768536837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,13286,80,1.18 [0.79-1.74],0.418279377626751
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,11661,71,1.04 [0.84-1.28],0.7207216872331518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,11705,70,0.96 [0.76-1.23],0.7650929226698877
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,13466,84,0.97 [0.80-1.18],0.7588145542941818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,11403,65,1.11 [0.66-1.88],0.6924923120356952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,11316,67,1.21 [0.93-1.58],0.1633233600303393
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,13534,81,1.07 [0.86-1.33],0.5384163897906543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,13485,85,1.17 [0.94-1.45],0.1613793820133785
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,13036,83,0.96 [0.78-1.18],0.6981840304898952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,13536,84,1.21 [0.88-1.64],0.2363906221170583
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,13572,84,0.88 [0.60-1.30],0.5361080390598433
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,13208,80,0.89 [0.48-1.66],0.7095384817534214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,11742,71,1.19 [0.84-1.68],0.3346336080657319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,13553,85,1.10 [0.74-1.63],0.639598628230752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,13294,81,1.14 [0.75-1.74],0.5392525263648607
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,13661,85,0.83 [0.64-1.08],0.1616813584646901
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,13532,85,0.92 [0.68-1.25],0.5894107971399397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",11378,66,0.75 [0.45-1.25],0.2681379661853916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,11399,68,1.26 [0.93-1.70],0.1366351908973489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,11487,69,1.06 [0.64-1.76],0.8153829993700604
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,13533,82,1.09 [0.92-1.30],0.3148016531597903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,11469,67,0.82 [0.57-1.16],0.2629447971805396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,13675,85,1.19 [0.66-2.17],0.5631751151160788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,11705,70,0.83 [0.37-1.90],0.6666699387593238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,11487,69,1.01 [0.58-1.75],0.982416566669234
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,11316,67,0.92 [0.48-1.78],0.8087359069666444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,11316,67,1.07 [0.82-1.38],0.6279481002979879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,13320,81,1.05 [0.81-1.35],0.7317976350524193
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,13485,85,0.93 [0.74-1.16],0.4963439256975088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,13589,85,1.00 [0.78-1.27],0.9684969783912586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,13553,85,1.01 [0.67-1.53],0.9651780326795242
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,11639,71,1.47 [0.99-2.19],0.0564149920462281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,11739,71,1.28 [0.58-2.84],0.5368982349543578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,11399,68,1.18 [0.84-1.66],0.3445109983800346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",11378,66,0.59 [0.28-1.25],0.167862339729838
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",11723,70,1.36 [0.96-1.94],0.082975515482414
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",13208,80,0.88 [0.41-1.87],0.7305187495232375
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",11302,67,0.60 [0.23-1.56],0.2917637424896125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",11723,70,1.04 [0.78-1.39],0.7667804153289095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",11403,65,1.15 [0.61-2.17],0.6684737019690202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,13471,85,0.96 [0.66-1.40],0.8484313968472782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,11399,68,1.24 [0.69-2.22],0.4792043704416876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,13502,86,0.95 [0.72-1.26],0.7210387119457475
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,13681,85,1.07 [0.70-1.62],0.7593531390712726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,13584,86,1.00 [0.77-1.29],0.9794782978169296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,11557,69,0.84 [0.64-1.11],0.220334746019205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,13320,81,1.43 [0.99-2.05],0.0564269722409174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,11403,65,0.96 [0.74-1.24],0.7465604977969689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",11705,70,0.99 [0.41-2.40],0.9907650704293238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,11487,69,1.01 [0.83-1.24],0.9002208225783238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",11676,70,0.86 [0.67-1.12],0.2598198232152653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,13320,81,0.74 [0.39-1.43],0.3765009915409443
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,11378,66,0.72 [0.46-1.15],0.1716696841281991
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,11676,70,1.05 [0.85-1.28],0.6528900967208568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,11661,71,1.16 [0.93-1.46],0.1882340886561602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,11487,69,0.79 [0.51-1.22],0.2821054734128717
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,13208,80,0.90 [0.61-1.33],0.5885975552015439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,13485,85,0.98 [0.89-1.09],0.7101966471379555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,11721,71,1.06 [0.83-1.36],0.6413249538486827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,11316,67,0.99 [0.60-1.62],0.9560847223358686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,13286,80,1.12 [0.88-1.43],0.3689437036012037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,11469,67,0.50 [0.24-1.04],0.0632892929118529
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",11742,71,0.88 [0.61-1.28],0.5030949995015286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",11416,69,0.94 [0.70-1.27],0.682375068493845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,11723,70,1.10 [0.82-1.48],0.5182123406298451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,11742,71,1.02 [0.81-1.27],0.8917368587287822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,11378,66,1.09 [0.69-1.73],0.701728067276953
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,11316,67,0.67 [0.36-1.24],0.2038698665166264
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,11721,71,1.03 [0.84-1.26],0.7547533885010783
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",11378,66,1.43 [0.99-2.08],0.0583796218085494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,11416,69,0.87 [0.62-1.23],0.4286589090010599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,11416,69,1.48 [1.06-2.07],0.0216306277843737
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,11399,68,1.03 [0.82-1.30],0.7989398385500703
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",11399,68,0.69 [0.35-1.37],0.2937112670719226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,11723,70,1.01 [0.57-1.76],0.9856137203564656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,13286,80,0.98 [0.73-1.32],0.8942738811415891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,13553,85,1.03 [0.68-1.55],0.9070023920593746
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,11396,68,1.18 [0.77-1.81],0.4486056148544763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,11378,66,0.67 [0.38-1.21],0.1841758694583572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,11469,67,0.81 [0.62-1.05],0.1124963287860018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,13593,84,0.67 [0.45-1.00],0.0522689420087753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,13241,84,0.90 [0.62-1.32],0.6022642645151277
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,11378,66,1.01 [0.64-1.58],0.9754378451662112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,11399,68,0.96 [0.79-1.16],0.6476431473421653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,13402,82,0.96 [0.68-1.34],0.7936536378554474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,11661,71,0.89 [0.58-1.38],0.606446481995147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,13551,82,1.20 [0.88-1.64],0.2496700728080887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,11383,65,0.91 [0.59-1.40],0.6768624688832753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,11392,69,0.93 [0.62-1.38],0.7215240973661964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,11469,67,1.31 [0.44-3.93],0.6239543143994667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,13241,84,1.30 [1.01-1.67],0.042218236080908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,11662,70,1.00 [0.59-1.71],0.9977162786565096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,11705,70,1.05 [0.53-2.08],0.8964070306122682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",11723,70,1.09 [0.68-1.74],0.7316642400221389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,13584,86,1.90 [0.92-3.93],0.0815489487545353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,13286,80,1.07 [0.76-1.51],0.7050658356346001
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,13563,86,1.44 [0.73-2.82],0.2921386270528271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,13553,85,1.53 [0.76-3.09],0.2319803076609389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,13681,85,1.15 [0.69-1.92],0.5990222974005351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,13517,80,1.24 [1.03-1.50],0.026337848968098
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,13610,85,0.99 [0.83-1.19],0.9372926031124652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,13286,80,0.87 [0.57-1.32],0.5144209138930227
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,13513,80,1.02 [0.59-1.77],0.9304434022245686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,11676,70,0.98 [0.49-1.97],0.9481363202971396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,13675,85,1.90 [0.98-3.68],0.0586709829663689
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,13208,80,0.90 [0.66-1.23],0.5082099336950526
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,11661,71,1.20 [0.93-1.56],0.1617220685508531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,11380,65,0.86 [0.44-1.69],0.6675615911632573
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,11676,70,0.92 [0.71-1.18],0.5166056855625412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",13241,84,0.93 [0.72-1.21],0.6080345678938437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,11378,66,0.78 [0.38-1.59],0.490295838708395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,11378,66,0.89 [0.61-1.30],0.5601584234388876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,11403,65,0.97 [0.46-2.02],0.9303321723067416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,13533,82,0.73 [0.36-1.50],0.3923220867974329
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,13584,86,1.26 [0.65-2.44],0.5021912584944246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,11403,65,1.14 [0.69-1.89],0.6177429322419418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,11403,65,1.02 [0.51-2.02],0.9551634754524448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,13164,80,1.86 [1.19-2.90],0.006165566103926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,11487,69,0.95 [0.69-1.33],0.780847917881772
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,13584,86,1.33 [0.85-2.10],0.2141103751154146
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,13610,85,1.45 [0.75-2.81],0.2666682552796932
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,11661,71,0.98 [0.80-1.21],0.8630866913421271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,11723,70,1.26 [0.50-3.21],0.6245014140974594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,11739,71,0.91 [0.65-1.27],0.5706658618416489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,13708,85,1.17 [0.59-2.31],0.6470699403413767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,11403,65,1.05 [0.81-1.37],0.6947624434505562
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",13534,81,1.04 [0.85-1.27],0.7305823968016555
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",13286,80,0.86 [0.61-1.22],0.4026066183003768
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,11416,69,0.97 [0.71-1.33],0.8712679110101682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,11723,70,1.00 [0.58-1.71],0.9964197045560294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,11378,66,1.00 [0.72-1.37],0.9799002195402726
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,11487,69,0.89 [0.56-1.41],0.6162671343326447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,13241,84,0.97 [0.65-1.44],0.8663673773408638
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",11676,70,0.91 [0.73-1.13],0.4005004204172837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,11378,66,1.32 [0.97-1.80],0.0769088767638509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,11378,66,1.58 [1.04-2.38],0.030225081208938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,13466,84,0.96 [0.21-4.31],0.9554729111430752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,11742,71,0.79 [0.34-1.81],0.576139631675806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,11705,70,1.10 [0.41-2.92],0.8481960510592881
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,11179,67,1.18 [0.57-2.45],0.6573052422773353
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,13524,86,1.18 [0.74-1.90],0.4825221316022531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,13553,85,1.14 [0.89-1.46],0.2969644737821282
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,13241,84,1.12 [0.85-1.49],0.4139045537908761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,11416,69,0.99 [0.62-1.58],0.9561115956280204
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,11707,71,1.04 [0.77-1.40],0.8019866183422419
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,11399,68,1.04 [0.75-1.44],0.8018112251182177
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,11396,68,0.65 [0.35-1.20],0.1673416305680251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,11403,65,1.34 [0.50-3.59],0.5557553464176568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,13572,84,1.15 [0.53-2.47],0.7215863786157004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,11618,70,1.07 [0.79-1.47],0.6552693363008899
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,13466,84,1.18 [0.96-1.47],0.1200403947975092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,11316,67,0.68 [0.33-1.40],0.2949466622629759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,11723,70,1.06 [0.77-1.45],0.7266004870737848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,13553,85,1.18 [0.55-2.55],0.6715100785255989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,11378,66,0.93 [0.74-1.17],0.5311208946289357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",13208,80,0.78 [0.52-1.17],0.2349481666215632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",11378,66,0.67 [0.35-1.29],0.2308023048934992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",13208,80,1.15 [0.81-1.63],0.4410040165992452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,13714,86,2.56 [0.80-8.23],0.114581976685165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,11721,71,1.13 [0.42-2.99],0.8134185209766978
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,13714,86,1.44 [0.85-2.45],0.1757837198456492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,11533,71,1.04 [0.49-2.23],0.9107813304742648
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,13551,82,1.23 [0.64-2.36],0.5320979300101017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,11403,65,1.43 [0.82-2.50],0.2022683861934948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,11403,65,0.93 [0.73-1.18],0.5485955713554574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,11742,71,1.34 [0.82-2.17],0.2392185040666351
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,13320,81,0.96 [0.83-1.12],0.5963640071224996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,13534,81,1.30 [0.85-1.97],0.2288947619231817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,11378,66,0.57 [0.27-1.19],0.135195492286326
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,13241,84,0.95 [0.75-1.21],0.6996497096974243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,13553,85,1.25 [0.79-1.99],0.3444228508751396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,11721,71,1.28 [0.65-2.52],0.4736286405814182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,13551,82,1.17 [0.69-1.97],0.5672643549173144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,13675,85,1.10 [0.83-1.46],0.5108445593487345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,13551,82,1.68 [0.87-3.23],0.1220308750043041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,11739,71,0.93 [0.73-1.18],0.5339565290548758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,11723,70,0.90 [0.45-1.79],0.7646366644733109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,13592,86,1.35 [0.69-2.62],0.3806608619211072
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,13553,85,1.14 [0.58-2.21],0.7067620298048758
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,13286,80,0.97 [0.65-1.46],0.8868539781766941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,11399,68,1.29 [0.72-2.29],0.3934454925515294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,13681,85,1.09 [0.83-1.45],0.5301058472634017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",11742,71,0.95 [0.71-1.29],0.758575084912786
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,11705,70,1.55 [0.96-2.49],0.0725919866666907
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,13514,80,0.99 [0.80-1.24],0.9588733006939006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,13584,86,1.44 [1.07-1.93],0.0160520745427043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,13534,81,0.63 [0.35-1.11],0.1067273634101137
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,13241,84,1.18 [0.78-1.80],0.4382282047499656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,13551,82,1.68 [0.80-3.56],0.1734125879527027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,13681,85,1.93 [0.80-4.67],0.1418516407372156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,13551,82,0.82 [0.66-1.02],0.0686820827981551
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,13534,81,0.93 [0.74-1.18],0.5605151122439349
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,11661,71,1.08 [0.87-1.34],0.4869915130013643
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,13650,85,1.04 [0.63-1.73],0.874817781931061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,13708,85,1.12 [0.83-1.51],0.471673013959684
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,11416,69,0.60 [0.21-1.75],0.3514186522877214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,11378,66,0.84 [0.50-1.40],0.4996363123028802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,11656,69,0.95 [0.74-1.24],0.7228752922671566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],13485,85,0.93 [0.66-1.30],0.6617947341136328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,13553,85,0.96 [0.67-1.39],0.8373589375728789
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,11403,65,1.05 [0.79-1.39],0.7266030048853538
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,11378,66,0.58 [0.24-1.40],0.2272363742490522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,11378,66,0.36 [0.14-0.88],0.0259329444045572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,13208,80,0.94 [0.55-1.60],0.8207760491680398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,11403,65,0.77 [0.35-1.70],0.521887938475334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,13421,83,1.19 [0.89-1.59],0.252183280642864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,11723,70,0.85 [0.49-1.47],0.5604555091276273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,13189,80,1.22 [0.89-1.67],0.2180117262266594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,11487,69,1.13 [0.86-1.48],0.3708343225015416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,11676,70,1.12 [0.82-1.55],0.4728889941551356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,13485,85,1.02 [0.56-1.84],0.9542923902310368
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,13553,85,1.16 [0.72-1.89],0.5366499551217658
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,11487,69,1.08 [0.77-1.52],0.6648059380535232
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,11042,65,0.92 [0.76-1.11],0.3693135988449105
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,13406,81,0.86 [0.61-1.21],0.3815179686891472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,13610,85,1.04 [0.68-1.60],0.8456737560013503
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,13485,85,0.87 [0.64-1.18],0.3743221435960517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,11396,68,1.18 [0.79-1.76],0.4098258776534029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,11705,70,1.02 [0.82-1.25],0.8761055047189305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,11416,69,1.01 [0.72-1.40],0.965032996740788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,13485,85,1.13 [0.75-1.69],0.5677678292310835
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,11710,70,1.13 [0.36-3.51],0.8319624894992711
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,11705,70,1.21 [0.77-1.91],0.4149710438420805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,13572,84,1.26 [0.70-2.26],0.4378961947465988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,13461,81,0.92 [0.70-1.20],0.5238942329642271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,13592,86,1.76 [0.72-4.32],0.2174272197527246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,11399,68,1.11 [0.69-1.78],0.6622488632886145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,11396,68,0.76 [0.46-1.27],0.2976421498086309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,11676,70,1.00 [0.69-1.46],0.9901123242771812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,11723,70,1.01 [0.71-1.43],0.9683394952460528
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",11416,69,0.77 [0.54-1.09],0.133368801429883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,13681,85,0.93 [0.80-1.07],0.2961280329955451
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,13476,85,0.90 [0.55-1.47],0.6721969406323987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,11378,66,0.85 [0.57-1.25],0.4023217094011799
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,13286,80,0.81 [0.54-1.22],0.3130350252956544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,13189,80,1.20 [0.96-1.49],0.1059776540757432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,13466,84,1.31 [1.16-1.48],1.9145150786584804e-05
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,11723,70,1.03 [0.85-1.24],0.7779358837450077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",11487,69,0.97 [0.60-1.54],0.8840181485947184
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,13320,81,0.83 [0.58-1.20],0.3167078694165837
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,11416,69,0.75 [0.42-1.33],0.3218025237292261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,11293,67,1.06 [0.69-1.64],0.7912308467250718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,13208,80,1.00 [0.72-1.38],0.9840539112621624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,11403,65,1.26 [0.79-1.99],0.3274115070056304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,11619,70,1.97 [0.99-3.91],0.0521691361844569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,11705,70,1.79 [1.10-2.90],0.0193886359030534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,11378,66,0.94 [0.67-1.33],0.7220176634203621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,13637,86,1.13 [0.56-2.29],0.7350763366282494
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,13553,85,0.99 [0.51-1.95],0.9881626088195062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,13286,80,1.00 [0.66-1.54],0.984269188322308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,11487,69,1.12 [0.84-1.50],0.4220640621635823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,13553,85,1.05 [0.74-1.50],0.7801042963500474
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,13534,81,0.76 [0.50-1.18],0.2262534937668873
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,11469,67,0.94 [0.56-1.58],0.819496706927636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,11316,67,0.94 [0.44-2.02],0.8788028718491487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,13208,80,1.12 [0.78-1.62],0.5401108880038559
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,11676,70,1.14 [0.57-2.27],0.7098952513075864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,11396,68,1.17 [0.95-1.44],0.1352461106533062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,11440,67,0.94 [0.58-1.52],0.8026617485910308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,11723,70,1.02 [0.74-1.39],0.9093255973966464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,13666,85,0.76 [0.29-1.98],0.5698764448255327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,11723,70,0.50 [0.20-1.23],0.1313720903288681
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,13551,82,1.34 [0.78-2.31],0.2873661114040466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,11676,70,0.87 [0.43-1.76],0.6938339859500623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,11676,70,1.05 [0.55-2.02],0.8812721184762764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,11661,71,0.86 [0.48-1.52],0.5998051030759929
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,11316,67,1.06 [0.77-1.47],0.7081726443673624
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,11661,71,0.85 [0.51-1.41],0.5253071203016129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,13714,86,0.83 [0.52-1.34],0.4503057004594608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,11676,70,0.99 [0.74-1.33],0.9535822048514714
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,11742,71,0.93 [0.74-1.18],0.5655720009833487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,13658,85,0.76 [0.47-1.22],0.2551463622596632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,13485,85,0.56 [0.30-1.05],0.0698839769431969
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,13681,85,1.16 [0.84-1.60],0.3643009190484629
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,13551,82,0.79 [0.64-0.97],0.0266988254920667
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,11316,67,0.82 [0.49-1.35],0.4305791976931006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",11316,67,1.03 [0.70-1.53],0.8759316125652437
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",11378,66,0.72 [0.44-1.19],0.2000238136255417
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",11469,67,0.93 [0.75-1.16],0.5267267607027317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,13714,86,1.01 [0.78-1.30],0.9563620515969906
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,13610,85,1.01 [0.81-1.25],0.93664538463464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,13241,84,2.11 [1.26-3.54],0.0047560932819389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,13551,82,1.89 [1.01-3.53],0.0459632762296523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,13714,86,1.58 [0.91-2.75],0.102447295493558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,11316,67,0.99 [0.54-1.81],0.970655347405464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,11469,67,0.74 [0.28-1.98],0.5459482471939759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,11721,71,0.94 [0.65-1.36],0.7490227301679109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,11316,67,0.97 [0.66-1.44],0.8935856263772992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,11723,70,0.99 [0.82-1.20],0.9576004544553756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,13610,85,1.01 [0.87-1.18],0.8618536858717845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",13241,84,0.85 [0.56-1.27],0.4241409305634572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,11399,68,1.26 [0.89-1.77],0.1887140605758859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,11316,67,0.61 [0.32-1.16],0.1327629670642092
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,11378,66,0.97 [0.65-1.45],0.896658553911016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,11403,65,0.83 [0.47-1.45],0.5033169146620122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,13714,86,0.75 [0.32-1.73],0.4964044400809347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,13553,85,0.98 [0.71-1.35],0.9019357416008764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,13553,85,0.97 [0.51-1.85],0.9287368126415364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,11416,69,0.43 [0.17-1.08],0.072653353475716
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,11469,67,1.54 [0.78-3.06],0.2148736198493182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,11739,71,2.20 [0.91-5.33],0.0793494298188959
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,11403,65,1.20 [0.98-1.45],0.0743527448185479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,11662,70,1.04 [0.82-1.30],0.7532762110892581
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,13208,80,1.05 [0.74-1.49],0.770571609739931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,11316,67,0.78 [0.48-1.26],0.3127849031904851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,11399,68,1.06 [0.76-1.46],0.7350859577882303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",13466,85,1.11 [0.87-1.41],0.4140015753291983
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,11739,71,1.09 [0.77-1.55],0.6304807137734476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",11742,71,1.00 [0.66-1.51],0.9821336943695504
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,13708,85,1.08 [0.51-2.29],0.8507775259144728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,13636,86,0.85 [0.53-1.36],0.5059063835970465
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,11591,69,2.59 [1.26-5.33],0.0096383800158968
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,11378,66,1.06 [0.74-1.51],0.7674627702586865
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,11399,68,1.04 [0.73-1.50],0.812566198216903
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,11403,65,0.98 [0.78-1.24],0.8915141330504804
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,11723,70,0.97 [0.80-1.18],0.7743160212797797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,11676,70,1.17 [0.77-1.78],0.4637603905700886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,11316,67,1.01 [0.79-1.29],0.9565917057828616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,13466,84,1.25 [0.63-2.46],0.5235639729984534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,11469,67,0.80 [0.47-1.38],0.4284973712166797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,11739,71,1.05 [0.42-2.63],0.917187181749886
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PI3,Elafin,13362,84,1.48 [1.09-2.01],0.0127604680860222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",11723,70,0.96 [0.72-1.29],0.7948760637764205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,13384,84,2.06 [1.23-3.45],0.0057281935525332
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,13534,81,1.20 [0.89-1.63],0.2382540486867258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,13553,85,1.09 [0.51-2.35],0.8250764510183815
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,11403,65,1.02 [0.68-1.54],0.9084702561283876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,13553,85,0.86 [0.55-1.35],0.5171683723106426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,13551,82,0.96 [0.68-1.33],0.7891476058823922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,11469,67,0.71 [0.51-0.99],0.0449211886796472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,11293,67,0.99 [0.74-1.32],0.9228096891656208
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,11742,71,1.24 [0.53-2.91],0.6251562992916482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,11378,66,1.07 [0.73-1.58],0.715170361101285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,13561,85,1.18 [0.90-1.54],0.2322847401334904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,11487,69,0.89 [0.66-1.21],0.4724784584332596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,13466,84,1.10 [0.80-1.51],0.5567529472552938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,13584,86,1.22 [0.60-2.50],0.5802769176771219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,13688,86,0.93 [0.59-1.46],0.7603578531834256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",13511,85,1.02 [0.74-1.42],0.8863060580518382
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,13610,85,0.99 [0.80-1.23],0.9274028255980252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,13553,85,0.80 [0.44-1.46],0.4748973799190507
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,13664,86,1.26 [0.87-1.83],0.2302364776295133
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,13553,85,1.33 [0.74-2.38],0.3376676437015026
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,13457,84,0.96 [0.45-2.06],0.9219182006635118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",11705,70,1.08 [0.73-1.58],0.7067288678142143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",11403,65,0.66 [0.36-1.22],0.1838052323955032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",11705,70,0.96 [0.76-1.20],0.6980556268373305
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,11705,70,0.96 [0.69-1.34],0.8327239671120168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,11428,69,0.53 [0.19-1.42],0.2035847413506518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,13208,80,0.96 [0.55-1.67],0.8728845478733926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,13551,82,0.87 [0.55-1.38],0.5511829802936252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,13551,82,1.04 [0.79-1.38],0.7763728793608575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,11691,69,1.05 [0.72-1.54],0.798872119003876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,13657,86,1.40 [0.81-2.42],0.2283328915355642
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,13241,84,0.66 [0.34-1.28],0.2179615131926696
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,11705,70,1.36 [0.63-2.92],0.4331978175089781
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,13534,81,0.95 [0.75-1.20],0.6643031105225423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,13650,86,0.82 [0.37-1.84],0.631287888071213
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,13508,81,1.09 [0.72-1.64],0.6768210414204364
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,13493,81,1.10 [0.98-1.24],0.092793919440272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,11378,66,0.86 [0.61-1.22],0.4048819225141322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,11378,66,0.77 [0.51-1.15],0.1974570153210446
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,11399,68,1.30 [0.87-1.93],0.2001651863130582
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,13187,80,0.99 [0.83-1.18],0.9301330354247628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,11739,71,1.04 [0.72-1.51],0.8214105346958933
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,11705,70,0.87 [0.64-1.17],0.3458490300627177
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,13547,84,0.97 [0.91-1.04],0.4130551916179924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,11416,69,0.89 [0.58-1.36],0.5890453656067647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,11396,68,0.76 [0.43-1.35],0.3546947018623759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",13286,80,0.99 [0.84-1.17],0.9281552514864116
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,13485,85,0.89 [0.26-3.07],0.8539729262041493
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,13584,86,1.52 [0.76-3.03],0.2310081128441541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,11403,65,0.68 [0.38-1.23],0.2034083093815741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,11403,65,0.83 [0.37-1.87],0.6579791342474186
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",13485,85,1.00 [0.57-1.74],0.999085559216798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,11416,69,1.26 [0.91-1.75],0.1649159868739971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,11739,71,1.08 [0.46-2.54],0.8636720633627928
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,13320,81,1.46 [0.83-2.56],0.1857682613613517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,13610,85,1.01 [0.55-1.85],0.9813395481304392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,11721,71,1.10 [0.60-1.99],0.7618189182715124
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,11656,70,1.11 [0.85-1.45],0.4370896176235183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,13681,85,1.14 [0.77-1.69],0.5074793978862718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,13540,86,1.00 [0.82-1.22],0.9961040050296602
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,11487,69,1.06 [0.76-1.48],0.7227815100695019
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",11721,71,0.86 [0.58-1.26],0.4353199237788338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,11403,65,1.55 [0.90-2.66],0.112341106258197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,13241,84,0.91 [0.48-1.73],0.7773598003848404
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,11403,65,0.91 [0.61-1.37],0.6595191470991797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,11742,71,0.86 [0.56-1.32],0.4797164914490586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,13485,85,1.10 [0.81-1.50],0.5434360297765046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,11661,71,0.90 [0.68-1.19],0.4584427526212623
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,13584,86,0.98 [0.80-1.19],0.8112819769336297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,11487,69,1.21 [0.95-1.54],0.1294750793617935
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,11723,70,0.97 [0.73-1.28],0.8244259619437331
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,11723,70,0.58 [0.29-1.17],0.1274903786147826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,13551,82,0.96 [0.76-1.23],0.7581355119532226
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,13708,85,1.04 [0.85-1.27],0.7111816689132467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,11676,70,1.04 [0.86-1.25],0.7060084682819185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,13466,84,1.03 [0.65-1.64],0.884455478214407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,11399,68,1.06 [0.80-1.41],0.6802536280987117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,13529,86,0.92 [0.76-1.12],0.4068656172852087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,13241,84,1.15 [0.85-1.56],0.373043638091285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,11316,67,0.59 [0.23-1.51],0.2686463331320096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,11721,71,1.08 [0.62-1.87],0.7830392976531169
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,11661,71,1.09 [0.75-1.58],0.6460986269518341
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,13624,86,0.78 [0.43-1.42],0.4188877225439719
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,13182,81,0.97 [0.77-1.21],0.7611024234393874
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,11538,69,1.28 [0.92-1.79],0.1481813229064429
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",13286,80,0.95 [0.72-1.24],0.6827764642399476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",13708,85,1.13 [0.85-1.50],0.3928588826038665
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,13675,85,1.24 [0.92-1.67],0.1535931521817487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,13286,80,1.22 [0.67-2.21],0.510667631247691
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,13547,84,1.10 [0.46-2.63],0.8337474075842476
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,11721,71,0.96 [0.62-1.48],0.8568133360821004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,11721,71,0.84 [0.54-1.30],0.4332968231067219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,13286,80,0.88 [0.60-1.29],0.5203388621412763
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,11399,68,1.69 [0.97-2.93],0.0638552758152334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,13551,82,0.93 [0.74-1.17],0.5519328920611994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,11685,70,1.09 [0.84-1.42],0.5273285992107634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,13286,80,1.12 [0.75-1.68],0.5690716699625565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,11378,66,1.26 [0.85-1.88],0.2437863814491143
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,11469,67,0.95 [0.79-1.14],0.5875734731417462
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,13241,84,0.99 [0.74-1.31],0.9214634334829296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,13681,85,1.07 [0.85-1.35],0.5721641346216904
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,11705,70,1.12 [0.74-1.68],0.5932102477928487
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,13545,86,0.81 [0.38-1.73],0.5856477064288076
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,11378,66,0.57 [0.24-1.32],0.1865114293230084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,13534,81,1.29 [1.00-1.66],0.0530240122345389
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,11750,70,0.81 [0.32-2.06],0.6517787610745807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,11399,67,0.99 [0.71-1.38],0.9475647001152252
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,11403,65,0.80 [0.47-1.37],0.4224410036678205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,11416,69,0.99 [0.53-1.85],0.9746195670457788
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,13563,86,0.87 [0.59-1.28],0.4784282261083682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,11403,65,1.69 [1.03-2.77],0.0370675763627156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,13501,82,1.33 [0.83-2.14],0.2367315897820285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,11705,70,1.30 [0.72-2.34],0.3789755591046336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,13490,85,1.21 [0.76-1.91],0.4200517852375082
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,13208,80,0.99 [0.83-1.18],0.8998736558074801
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,13675,85,1.28 [0.62-2.65],0.504619035178566
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,13192,82,0.80 [0.51-1.25],0.3335102076990309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,11487,69,1.17 [0.53-2.56],0.7031284885379887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,11614,71,0.98 [0.44-2.19],0.9664076791767396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,11676,70,1.23 [0.79-1.92],0.3691202829073371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,11676,70,1.00 [0.92-1.10],0.9485657538105392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,13466,84,0.98 [0.83-1.16],0.8452230251602042
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,13534,81,0.93 [0.68-1.28],0.6622275995233777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,13241,84,0.74 [0.46-1.17],0.1943240984416281
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,11316,67,1.58 [0.76-3.29],0.2216483498083357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,11723,70,0.88 [0.55-1.41],0.5956550488175756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,11399,68,1.07 [0.74-1.55],0.7294063793884402
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,13485,85,1.15 [0.83-1.58],0.3987407246592194
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,13448,84,1.18 [0.71-1.95],0.519101781704919
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,13401,84,1.18 [0.71-1.96],0.5316022989309062
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,13534,81,1.19 [0.82-1.73],0.3467703589219771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,11403,65,1.17 [0.79-1.72],0.4329704853759755
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,13534,81,1.03 [0.86-1.24],0.7269937353140697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,13241,84,0.92 [0.66-1.28],0.6299740456178125
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,11032,64,1.04 [0.83-1.29],0.7568628292639066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",13208,80,1.16 [0.61-2.22],0.6494050283027735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,13413,85,1.60 [0.86-3.00],0.1401257032079322
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,11314,63,0.94 [0.61-1.44],0.7644812536070975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,11742,71,1.20 [0.92-1.56],0.1900368937251335
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,11399,68,1.24 [0.94-1.63],0.121669988285971
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,13534,81,1.11 [0.68-1.79],0.6790272144890651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,13208,80,1.85 [1.17-2.93],0.0083809233486214
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,13320,81,0.92 [0.62-1.36],0.6710415644594869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,11403,65,0.93 [0.59-1.48],0.7655085113935537
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,13466,84,1.06 [0.83-1.35],0.6450107235113531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,13589,85,0.98 [0.80-1.21],0.8832653963679843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,11377,65,1.07 [0.59-1.91],0.8318238442849211
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,11742,71,1.13 [0.53-2.40],0.7463272077541911
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,11721,71,0.78 [0.29-2.11],0.6204192709505816
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,13714,86,1.16 [0.61-2.21],0.6576358897969408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,11676,70,1.50 [0.98-2.30],0.0626120418652981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,11676,70,1.15 [0.45-2.92],0.774520221240477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,13508,81,0.81 [0.36-1.81],0.6068546353356044
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,13414,84,1.10 [0.59-2.05],0.7720165529331606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,11705,70,1.06 [0.57-1.98],0.8485991859672058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,13714,86,1.69 [0.78-3.67],0.1816561287579827
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,11742,71,0.57 [0.28-1.15],0.1161296249659027
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,11469,67,1.01 [0.69-1.49],0.945633230489639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,13152,79,1.19 [0.87-1.63],0.2690236188941398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,11487,69,1.40 [0.89-2.19],0.1427398164472356
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,13534,81,0.85 [0.59-1.22],0.3703706277867077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,13618,84,0.99 [0.84-1.17],0.9289545050118948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,13681,85,1.70 [1.08-2.69],0.0220238248581183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,11661,71,1.07 [0.74-1.54],0.7320064317396061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,13208,80,1.34 [0.98-1.84],0.0682112096540302
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,11416,69,0.88 [0.50-1.57],0.6746285511503303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,11378,66,0.98 [0.76-1.26],0.8611819459436336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,11750,70,0.70 [0.49-1.00],0.0475994012657258
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,13494,82,0.88 [0.56-1.37],0.5614777324854392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,13555,86,0.88 [0.43-1.82],0.7337902888430448
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,11501,70,1.12 [0.71-1.77],0.6134484429015189
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,11742,71,0.84 [0.55-1.29],0.4352204279293663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,11742,71,0.99 [0.80-1.21],0.8861844551688285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,11742,71,0.95 [0.73-1.24],0.6896662875541006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,11661,71,1.01 [0.71-1.45],0.9527870405030948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,11378,66,1.01 [0.71-1.44],0.940615114757736
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,13286,80,0.95 [0.74-1.21],0.6642543568881406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,11378,66,0.92 [0.68-1.23],0.5569591451847942
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,11396,68,0.77 [0.47-1.25],0.2877932756266618
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,11661,71,1.35 [0.97-1.89],0.0741242703925608
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,13534,81,1.20 [0.81-1.76],0.3614746708693479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,13208,80,1.04 [0.69-1.55],0.8598549403991421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,11469,67,0.98 [0.72-1.32],0.8760809020123115
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,13241,84,0.90 [0.64-1.26],0.5354223382156109
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,13286,80,1.13 [0.82-1.55],0.4631444019847993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,11399,68,1.05 [0.77-1.44],0.7482900480411447
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,13241,84,0.88 [0.58-1.34],0.5532447411131257
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,11487,69,1.05 [0.72-1.55],0.787181386959982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,11403,65,1.41 [0.64-3.11],0.3979041898742856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,11661,71,0.84 [0.51-1.39],0.5031470217864482
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,11416,69,1.02 [0.66-1.57],0.9421061964750496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,11396,68,0.63 [0.30-1.32],0.2204692731046998
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,13241,84,0.65 [0.41-1.05],0.0777283443469397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,11403,65,0.66 [0.41-1.05],0.081749733239233
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,11487,69,0.90 [0.57-1.41],0.6336790976746544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,13241,84,0.62 [0.31-1.24],0.1793328780403428
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,13592,86,0.83 [0.55-1.25],0.3715965372479649
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,13208,80,1.05 [0.58-1.89],0.8691735396550596
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,11316,67,0.82 [0.47-1.44],0.4825774013219222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,13241,84,1.20 [0.92-1.57],0.1849188397149376
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,11723,70,1.09 [0.60-1.96],0.7810307332147777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,13225,81,1.07 [0.73-1.56],0.7258246731366742
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,11723,70,0.94 [0.70-1.26],0.6683878549330489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,11378,66,0.69 [0.37-1.27],0.2317743983376848
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,11316,67,0.68 [0.39-1.16],0.1531417611951586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,11399,68,1.18 [0.91-1.53],0.2068467761978029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,13485,85,1.00 [0.77-1.29],0.9995399771596524
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,13485,85,1.11 [0.80-1.53],0.5389070246866992
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,11676,70,1.01 [0.70-1.47],0.9497745401704256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,11403,65,1.27 [0.96-1.67],0.0917445190585173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,11416,69,0.97 [0.78-1.21],0.7937843349310565
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,11661,71,1.21 [0.85-1.73],0.2888802695873925
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,13320,81,0.94 [0.59-1.51],0.7999179655139157
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,11416,69,1.16 [0.38-3.58],0.7968623137892004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,11723,70,1.06 [0.75-1.52],0.7273408023417319
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,13448,86,0.73 [0.47-1.13],0.1637882565961697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,13714,86,0.75 [0.51-1.09],0.129459915635756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,13714,86,0.85 [0.61-1.18],0.3374798160755945
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,11661,71,0.91 [0.52-1.59],0.7367739734181262
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,13572,84,0.67 [0.44-1.02],0.0616577548277362
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,11403,65,0.89 [0.54-1.46],0.6328462654077955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,13553,85,1.77 [0.87-3.61],0.1180147564478987
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REN,Renin,13551,82,1.08 [0.83-1.40],0.5775727001235452
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,11403,65,0.60 [0.30-1.18],0.137406090681261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,11316,67,0.51 [0.24-1.10],0.0853450073001427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,13485,85,1.31 [0.84-2.04],0.2336751242432397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RETN,Resistin,13494,85,0.76 [0.47-1.23],0.2652600882966314
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",11378,66,1.27 [0.88-1.82],0.1995256653281615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,11661,71,1.91 [0.79-4.61],0.1508846942510093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,11723,70,1.01 [0.75-1.36],0.9361414836284936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,11487,69,0.95 [0.66-1.36],0.7747421940645556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,13681,85,1.75 [0.94-3.26],0.0755299344180095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,13681,85,1.08 [0.51-2.31],0.8418809170306836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,11723,70,0.94 [0.64-1.37],0.7376855678492358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,13286,80,1.20 [0.94-1.53],0.1475412919069641
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,13369,84,0.96 [0.82-1.13],0.6268444983711869
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,11403,65,1.26 [0.84-1.88],0.2628277859293064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,11469,67,1.02 [0.64-1.62],0.9368539483493802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,13638,85,1.21 [0.89-1.64],0.2308195079884981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,11742,71,0.94 [0.75-1.18],0.5820431305735296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,11378,66,1.09 [0.80-1.50],0.5811843028834427
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,11723,70,1.18 [0.98-1.44],0.0856315292864406
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,11453,67,1.12 [0.99-1.26],0.0721707389072893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,11739,71,1.66 [0.66-4.17],0.2836826209206294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,11416,69,0.79 [0.48-1.30],0.3475586694441235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,13483,82,1.03 [0.86-1.22],0.7746802161697308
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,11343,70,0.80 [0.32-1.98],0.633228725763777
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,11647,71,0.81 [0.34-1.97],0.6468087882738306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,11723,70,1.03 [0.67-1.58],0.8984770377424265
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,13646,86,0.87 [0.41-1.84],0.7069637163216009
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,11416,69,0.82 [0.38-1.80],0.6285861417514639
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,11403,65,0.88 [0.48-1.63],0.6933233004857994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,11403,65,0.49 [0.21-1.12],0.0912609690179572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,11487,69,0.99 [0.70-1.39],0.9432982549414464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,13241,84,1.06 [0.81-1.40],0.6571489699998025
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,11487,69,1.02 [0.71-1.47],0.8958195905503459
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,11416,69,0.90 [0.67-1.22],0.510299755049384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,13572,84,1.31 [0.62-2.76],0.4824388013522741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,13681,85,1.44 [0.63-3.30],0.3887123202429855
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,11416,69,0.52 [0.20-1.34],0.1758920944835441
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,13551,82,1.06 [0.57-1.99],0.8460786883890802
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,13485,85,1.30 [0.86-1.96],0.2178946709622161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,11403,65,0.81 [0.38-1.74],0.5829337850850547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,11487,69,0.91 [0.65-1.27],0.588009948442713
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,11399,68,0.91 [0.50-1.65],0.7471958010669962
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,11416,69,1.13 [0.69-1.85],0.6382910715219519
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,11378,66,0.56 [0.28-1.11],0.0977981749786117
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,11399,68,0.92 [0.77-1.10],0.3738698411692391
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,13241,84,0.86 [0.57-1.31],0.4910017446561434
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,13241,84,1.06 [0.80-1.40],0.680303846858888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,11396,68,0.95 [0.73-1.22],0.679168127977416
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,13466,84,1.76 [1.07-2.91],0.0270239993236656
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,13675,85,0.93 [0.47-1.86],0.8407683994669384
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,13485,85,0.92 [0.47-1.81],0.8144017701417572
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,11378,66,1.29 [0.94-1.78],0.1121589832511286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",11723,70,0.90 [0.71-1.15],0.4181469251252883
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,13675,85,1.54 [1.00-2.36],0.0491607098484715
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,13241,84,0.96 [0.79-1.16],0.6426595549052483
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,13681,85,0.97 [0.73-1.30],0.8564390910153876
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,11378,66,0.67 [0.30-1.52],0.3393508376172114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,13438,82,1.01 [0.67-1.52],0.9667123638410028
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,13369,85,1.14 [0.88-1.46],0.3167076406794052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,11403,65,0.97 [0.49-1.92],0.919950423121606
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,11723,70,1.11 [0.71-1.71],0.6529926135933477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,13189,80,1.01 [0.74-1.39],0.9321750113707366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,11661,71,0.97 [0.58-1.62],0.9032388853916584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,13584,86,1.08 [0.77-1.50],0.6631717150983122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,11723,70,1.24 [0.76-2.02],0.3998025702871853
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,13320,81,1.19 [0.86-1.66],0.2898722229281064
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,11750,70,1.34 [0.84-2.14],0.2226385395812318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,11723,70,0.90 [0.39-2.05],0.7990083527335636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,11396,68,1.15 [0.79-1.68],0.4728921442256478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,13534,81,0.92 [0.71-1.21],0.5701626008894085
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,11487,69,1.11 [0.85-1.46],0.4274256833046018
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,11701,70,0.98 [0.79-1.20],0.8184775258372843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,11378,66,1.21 [0.73-1.99],0.4654377631216454
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,11378,66,1.27 [0.89-1.79],0.1846196896378558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,11487,69,1.19 [0.91-1.56],0.2016553993722191
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,11723,70,1.16 [0.62-2.18],0.6345554243212668
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,11697,71,0.79 [0.41-1.55],0.4980804506321891
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,13485,85,1.00 [0.80-1.25],0.9850026261908976
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,13681,85,1.60 [0.83-3.09],0.1621452700163845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,13208,80,1.03 [0.73-1.44],0.8768788471831517
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,13209,80,1.22 [0.61-2.42],0.5727253874900757
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,13714,86,0.98 [0.63-1.52],0.924343442420309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,13681,85,1.13 [0.59-2.18],0.714909021270709
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,13613,85,1.04 [0.57-1.89],0.902681846832266
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,13572,84,1.10 [0.62-1.97],0.7415820126959463
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,13574,85,1.01 [0.71-1.42],0.9679165355508192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,11378,66,0.73 [0.31-1.72],0.4759092551603392
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,11469,67,0.75 [0.28-1.99],0.5641645451531243
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,13589,85,0.96 [0.77-1.20],0.7231335985167728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,13286,80,0.79 [0.49-1.27],0.3299729889523197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,11396,68,1.03 [0.75-1.41],0.8494402782804202
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,13638,85,1.17 [0.81-1.70],0.401699910558132
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,11396,68,1.38 [0.99-1.92],0.0549495724733004
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,11399,68,0.63 [0.26-1.54],0.3065003603409989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,11399,68,0.89 [0.48-1.67],0.7209131431542083
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,11396,68,1.59 [1.22-2.08],0.0006405455652481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,11416,69,0.88 [0.51-1.54],0.6617179215679974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,13241,84,0.90 [0.69-1.17],0.4479774921043949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,11374,69,0.94 [0.59-1.49],0.7904085569456653
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,11742,71,0.99 [0.43-2.26],0.9728551903284752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,11416,69,1.17 [0.94-1.45],0.1624469918235279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,13534,81,1.08 [0.78-1.51],0.6466024525315761
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SCT,Secretin,11399,68,0.88 [0.51-1.51],0.6416006144646328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,13551,82,0.94 [0.57-1.57],0.8203313090851702
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,13551,82,1.02 [0.66-1.56],0.9444487238438412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,11661,71,1.03 [0.85-1.26],0.7598123327029198
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,11676,70,0.95 [0.69-1.32],0.775319164912097
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,11469,67,0.85 [0.45-1.63],0.6310937569030924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,11416,69,0.85 [0.63-1.13],0.2626395676526267
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,11416,69,0.77 [0.33-1.79],0.5493018236620564
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,13714,86,0.71 [0.49-1.02],0.0608342646743327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,11750,70,0.72 [0.25-2.06],0.5358282307192472
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,11750,70,1.22 [0.45-3.30],0.6970595347681954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,13563,86,1.04 [0.75-1.43],0.8267352091602246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,13534,81,0.81 [0.42-1.55],0.5168614343877312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,13551,82,1.17 [0.55-2.49],0.6879602553745972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,11469,67,0.51 [0.29-0.93],0.026442148585613
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,13485,85,0.57 [0.27-1.24],0.1563826235231456
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,13681,85,0.73 [0.39-1.37],0.3236117602965145
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,11403,65,1.03 [0.44-2.43],0.9489179623900704
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,13664,86,0.93 [0.45-1.92],0.8542353636888079
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,11723,70,1.15 [0.86-1.53],0.3463002692172925
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,11487,69,1.04 [0.69-1.58],0.8470778524840843
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,11677,70,1.27 [0.66-2.45],0.4778867220991954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,13485,85,0.89 [0.44-1.79],0.7440820988311285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,11521,68,0.68 [0.04-12.68],0.7963488256611411
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,13714,86,0.80 [0.50-1.26],0.329684237280892
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,13188,80,0.90 [0.74-1.09],0.2818719415016662
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,11710,70,1.24 [0.26-5.99],0.7920533806134508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,11522,70,1.99 [0.78-5.09],0.1497396249014261
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,11566,70,1.39 [0.75-2.58],0.2938794510626444
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,11750,70,0.60 [0.16-2.18],0.4331058215566312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,11750,70,0.88 [0.26-2.91],0.8280535641181486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,13405,85,0.69 [0.53-0.91],0.0071236746370775
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,13511,85,1.01 [0.82-1.25],0.9006863399087439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,13320,81,1.02 [0.68-1.52],0.932558879508796
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,13638,84,0.89 [0.65-1.23],0.4830192686525032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,13708,85,1.07 [0.78-1.47],0.6657120472795096
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,13466,84,0.93 [0.54-1.61],0.8005261943584147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,11723,70,1.54 [0.33-7.11],0.5807851021817776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,11723,70,1.30 [0.58-2.94],0.5273730171679312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,13714,86,1.26 [0.95-1.67],0.1092179667686289
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,11742,71,1.16 [0.83-1.62],0.381696330128129
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,11574,68,1.87 [0.82-4.29],0.1368730815687571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,11523,68,1.42 [0.26-7.66],0.684102705065682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,11723,70,1.15 [0.34-3.83],0.8237785044484238
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,11487,69,0.99 [0.83-1.19],0.945718358621286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,11440,67,0.82 [0.39-1.74],0.6091947979164678
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,11676,70,1.00 [0.67-1.49],0.9954480537940084
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,13208,80,0.81 [0.59-1.11],0.1925644172549279
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,13428,82,1.00 [0.52-1.92],0.9920636524940794
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,11399,68,0.67 [0.30-1.51],0.3397829378774767
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,13584,86,1.70 [0.85-3.41],0.1361577774361563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,13485,85,1.56 [0.74-3.29],0.2430919623190599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,13485,85,1.01 [0.79-1.31],0.9088258926488396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,13421,83,1.07 [0.68-1.69],0.7600359945478685
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,11469,67,1.51 [0.87-2.60],0.1399701838986977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,13241,84,1.17 [0.88-1.56],0.2856728263328646
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,13241,84,1.01 [0.68-1.50],0.9453910383363372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,13551,82,1.02 [0.76-1.39],0.8781411928322522
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,11550,71,0.86 [0.56-1.32],0.4925859974639316
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,13241,84,1.04 [0.85-1.26],0.7243915323588592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,13534,81,0.83 [0.56-1.23],0.3507073034364895
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,11396,68,0.92 [0.61-1.38],0.6874294216885246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,11676,70,1.21 [0.81-1.81],0.3488520087536367
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,11425,68,0.89 [0.69-1.15],0.3646312078078922
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,11705,70,1.02 [0.73-1.43],0.8862701455208921
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,11739,71,0.55 [0.38-0.81],0.002249549317104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,11316,67,0.93 [0.75-1.15],0.4938905256300542
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,11358,66,1.17 [0.95-1.45],0.1435016460259024
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,11403,65,1.03 [0.60-1.78],0.9057818293897616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,11721,71,1.05 [0.40-2.75],0.9281310522071856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",13589,85,1.06 [0.85-1.31],0.5992667229278845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,11487,69,0.44 [0.21-0.93],0.0308264754339589
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,13561,86,0.97 [0.65-1.45],0.8949562694270317
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,13610,85,1.28 [0.83-1.97],0.2585815626619817
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,13534,81,1.52 [0.85-2.72],0.1587969155031699
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,13208,80,1.04 [0.83-1.31],0.7225384444915985
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,13553,85,0.95 [0.82-1.11],0.5429746467523544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,13675,85,0.86 [0.47-1.54],0.6043534895056136
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,13551,82,0.82 [0.42-1.60],0.5543252259116473
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,11416,69,1.77 [1.09-2.86],0.0199599070114148
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,13659,85,0.94 [0.50-1.77],0.8523885503268263
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,11416,69,0.65 [0.27-1.59],0.3470102561240241
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,13573,86,1.11 [0.79-1.57],0.5467955845535871
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,13519,84,0.96 [0.62-1.49],0.8617515495821887
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,11403,65,0.89 [0.65-1.21],0.4502262531533413
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,13485,85,0.97 [0.79-1.20],0.7813753175338575
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",13208,80,0.82 [0.55-1.22],0.3265610204125286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,13286,80,0.86 [0.60-1.23],0.4149480103222502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,13437,84,0.98 [0.76-1.27],0.903627089529077
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,13610,85,0.97 [0.81-1.17],0.7797335670924309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,11378,66,0.59 [0.29-1.18],0.1359346160109363
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,11723,70,0.93 [0.75-1.15],0.5067073217022107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,13286,80,1.25 [0.88-1.76],0.2085997040708418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,13241,84,0.99 [0.59-1.67],0.9795818802228878
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,13534,81,0.80 [0.57-1.14],0.2177410089297321
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,13241,84,1.02 [0.71-1.46],0.9079114382092912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,11378,66,0.57 [0.22-1.47],0.2455461485165571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,11661,71,0.98 [0.67-1.43],0.9057284044922272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,13208,80,1.26 [0.97-1.64],0.0869657389404274
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,11399,68,1.14 [0.77-1.69],0.5089080286677496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,13208,80,1.07 [0.80-1.42],0.6600574309934195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,11316,67,0.94 [0.63-1.40],0.755846781433423
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,11316,67,1.31 [0.91-1.88],0.148592937688671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,13208,80,1.06 [0.58-1.93],0.8544813972027313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,13534,81,1.10 [0.78-1.54],0.5957350116347107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,11399,68,0.92 [0.64-1.32],0.6429901040558088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,11721,71,0.90 [0.55-1.47],0.6720876997180657
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,11378,66,0.92 [0.67-1.26],0.5833523321666977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,11469,67,0.88 [0.67-1.17],0.3863961008209807
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,11676,70,1.15 [0.84-1.58],0.3895418455134372
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",11316,67,0.79 [0.49-1.27],0.3336732835137553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,13208,80,1.28 [0.93-1.78],0.1325916111307328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,11403,65,1.39 [0.67-2.87],0.3776147115247225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,13675,85,1.42 [0.86-2.36],0.1728210188547634
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,13320,81,0.85 [0.48-1.53],0.5913824843861348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,11487,69,1.04 [0.79-1.36],0.7759326525378599
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,11676,70,1.02 [0.78-1.33],0.8821061493710776
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,11633,71,1.06 [0.60-1.88],0.8395533530632556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,13241,84,1.00 [0.79-1.27],0.9936693807503924
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,11661,71,0.94 [0.67-1.31],0.7091073352571671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,11661,71,0.81 [0.51-1.29],0.3700179456797386
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,13485,85,1.45 [0.56-3.78],0.4428922261538831
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,13208,80,0.89 [0.67-1.18],0.4270179570245574
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,11316,67,1.26 [0.90-1.75],0.1739659012404093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,11676,70,1.06 [0.76-1.48],0.7391926242819176
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,13675,85,1.12 [0.63-1.99],0.7061675664219977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,13610,85,1.95 [1.26-3.02],0.0027208175172598
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,13614,84,0.82 [0.54-1.23],0.3384382587365347
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,11403,65,0.71 [0.41-1.22],0.2114290937607061
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,13582,85,0.96 [0.71-1.29],0.7903993084708558
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,11661,71,1.08 [0.83-1.41],0.5506209348134858
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,11396,68,0.89 [0.61-1.32],0.5683531194458955
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,11679,70,1.07 [0.85-1.33],0.5836459257466102
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,13551,82,0.97 [0.78-1.21],0.8109216538370728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,11396,68,0.94 [0.58-1.52],0.7897263823160616
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,13584,86,0.99 [0.81-1.22],0.942488691276203
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,11723,70,1.00 [0.68-1.48],0.9963341967480632
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,11469,67,1.01 [0.83-1.24],0.925721900171246
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,13466,84,1.01 [0.76-1.36],0.9220209444359748
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",11416,69,1.42 [0.79-2.58],0.2436869751036534
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',11705,70,1.10 [0.72-1.68],0.6528037132594229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,11378,66,1.30 [1.00-1.69],0.0515979452259496
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,11469,67,0.92 [0.60-1.42],0.7184099529722052
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,11676,70,1.10 [0.69-1.76],0.6773810219874674
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,11661,71,1.07 [0.81-1.41],0.6500735816034144
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,11416,69,1.35 [0.67-2.71],0.404604687289165
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,13551,82,0.94 [0.71-1.25],0.6934364895001344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],13225,83,1.02 [0.69-1.52],0.9216891320056286
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",13553,85,0.84 [0.51-1.38],0.4854664937821039
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,11739,71,1.04 [0.73-1.47],0.8362492261011647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,11723,70,1.05 [0.60-1.85],0.862287493670288
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,13241,84,1.17 [0.66-2.04],0.5940493647005523
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,13612,85,1.07 [0.81-1.41],0.6372545823678086
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,13533,82,1.12 [0.66-1.88],0.67393112391486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,13533,82,1.15 [0.70-1.89],0.5849357439072312
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,11399,68,0.84 [0.49-1.44],0.5279338798975237
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,11709,70,0.94 [0.36-2.48],0.9045331682350964
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,11399,68,1.06 [0.45-2.53],0.8882869202469161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,11723,70,0.59 [0.24-1.44],0.2461589499437733
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,11723,70,1.02 [0.71-1.48],0.9077648702487344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,13584,86,0.94 [0.72-1.21],0.6177564311105306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,13520,85,1.42 [0.72-2.82],0.314157009518449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPART,Spartin,11469,67,0.97 [0.72-1.31],0.8437726808924659
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,11742,71,0.39 [0.16-0.91],0.0298518344125975
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,13553,85,1.07 [0.70-1.64],0.7429393639419735
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,11469,67,0.71 [0.38-1.32],0.2809937670528457
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,13534,81,0.91 [0.66-1.25],0.5510890618384996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,13553,85,1.79 [1.00-3.18],0.0496701920275982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,13675,85,0.87 [0.62-1.23],0.4396718049331197
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,11378,66,0.51 [0.23-1.13],0.097342754324661
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,13509,85,1.98 [1.05-3.71],0.0342022963153539
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,13610,85,0.92 [0.59-1.45],0.7285265469411766
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,11676,70,0.91 [0.77-1.08],0.2913127102392182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,13466,84,1.70 [0.82-3.55],0.1542330035304455
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,13572,84,1.46 [0.82-2.58],0.1985324489266229
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,13489,82,0.88 [0.50-1.56],0.6629308885356682
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,13686,86,1.01 [0.67-1.53],0.9441189986570782
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",11403,65,0.70 [0.38-1.27],0.2379900570299578
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,11316,67,1.10 [0.76-1.58],0.6110037556092677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,11487,69,1.08 [0.86-1.36],0.5005707525274021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,11705,70,1.13 [0.82-1.55],0.4595375345138806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,13286,80,1.09 [0.89-1.34],0.3960236316195149
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",11396,68,1.06 [0.53-2.12],0.8701864053101778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,11705,70,0.98 [0.52-1.84],0.9435922485791304
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,13561,86,0.97 [0.83-1.13],0.6946300429354167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,13485,85,1.10 [0.81-1.48],0.5426657619099806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,13534,81,0.98 [0.78-1.24],0.8608803921011126
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,11742,71,0.96 [0.48-1.92],0.9157881264555764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,13208,80,1.36 [1.14-1.63],0.0007753828777426
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",11403,65,0.87 [0.42-1.78],0.696725568428721
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,13533,82,1.15 [0.98-1.36],0.0860914957096543
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,13563,86,1.34 [0.86-2.08],0.1999894385869147
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,11316,67,0.66 [0.28-1.56],0.3401568838512749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,11676,70,1.04 [0.68-1.60],0.8464262982724569
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,11469,67,0.96 [0.64-1.45],0.845874571868897
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",13485,85,1.02 [0.66-1.59],0.9193226562745864
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",13714,86,1.03 [0.53-2.00],0.927448336852396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",11403,65,0.92 [0.55-1.56],0.7664252296214931
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,11721,71,0.83 [0.38-1.83],0.6451081713416231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,11661,71,1.04 [0.58-1.87],0.9016007883918972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,13437,84,1.04 [0.77-1.39],0.8022207817325502
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,11403,65,0.97 [0.71-1.33],0.8607104567162195
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,13485,85,0.98 [0.86-1.13],0.798460799297753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,11316,67,1.19 [0.88-1.60],0.2617027549489256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,13681,85,1.07 [0.68-1.70],0.7640339756556823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,13530,85,2.22 [1.04-4.71],0.0385793904726058
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,11396,68,0.97 [0.70-1.34],0.8457890112936552
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,13532,85,1.01 [0.76-1.34],0.9616541438000432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,13320,81,1.04 [0.80-1.35],0.7788975508203823
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,13208,80,0.83 [0.60-1.15],0.2684777497791477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,13551,82,0.99 [0.79-1.23],0.9105121008373056
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",11316,67,0.98 [0.76-1.27],0.8862568005153248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,13241,84,1.10 [0.79-1.51],0.5783285056682477
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,11399,68,0.96 [0.55-1.66],0.874811783341547
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,11705,70,0.84 [0.45-1.58],0.5888271466432676
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,13485,85,1.04 [0.76-1.43],0.7896074002457029
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,11403,65,0.88 [0.48-1.62],0.6769874386591205
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,13241,84,1.02 [0.77-1.34],0.8906919051430956
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,11403,65,1.34 [0.84-2.14],0.2157463331906833
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,13534,81,1.02 [0.68-1.51],0.9368546347348466
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,11723,70,0.97 [0.73-1.29],0.8203191343091967
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,13241,84,0.91 [0.58-1.45],0.697709830307099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,11676,70,1.14 [0.67-1.93],0.6217410113863888
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,13241,84,1.06 [0.84-1.35],0.6119493671236664
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,13681,85,0.99 [0.86-1.15],0.9183490535590996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,13534,81,0.86 [0.59-1.25],0.4198195383114994
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,11403,65,1.00 [0.72-1.38],0.9894186963108138
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,13681,85,1.12 [0.78-1.60],0.5471975759978256
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",11723,70,1.07 [0.76-1.51],0.6858945666321637
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,13320,81,0.95 [0.63-1.41],0.785965660972966
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,13553,85,1.85 [0.98-3.48],0.0576216121889275
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,11661,71,0.65 [0.38-1.13],0.128115848190041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,11401,67,0.65 [0.33-1.27],0.2058067017252293
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,11399,68,1.20 [0.86-1.67],0.2931206630913021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,11676,70,0.95 [0.50-1.80],0.8817111770379371
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,11469,67,1.02 [0.68-1.54],0.9093681287155492
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,11396,68,0.90 [0.57-1.40],0.6269381178955923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,11705,70,1.00 [0.55-1.81],0.9984151241490464
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,11742,71,0.92 [0.67-1.26],0.6125959967513898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,11487,69,0.99 [0.80-1.23],0.9571007266064784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,13485,85,0.98 [0.83-1.15],0.8141739785874512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,12012,77,0.99 [0.49-2.00],0.969152400320586
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,11661,71,0.80 [0.45-1.43],0.4516106013818651
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,13485,85,1.73 [1.01-2.98],0.0471386738400468
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,11316,67,1.02 [0.70-1.48],0.9219601756950622
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,11680,71,1.02 [0.63-1.67],0.9336099508976908
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,13286,80,1.26 [0.96-1.66],0.0948234839064938
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,11487,69,1.00 [0.67-1.48],0.988843849996192
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,13208,80,1.01 [0.79-1.30],0.91522858428818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",11399,68,1.20 [0.94-1.53],0.1392854474814035
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",11661,71,0.96 [0.52-1.78],0.8999072974137857
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,11705,70,1.04 [0.73-1.47],0.8289947905934885
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,13208,80,1.15 [0.77-1.72],0.5015428536135875
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,13485,85,0.99 [0.80-1.22],0.9119472297584692
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,13534,81,1.08 [0.85-1.37],0.5319681004926182
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,11469,67,1.00 [0.77-1.30],0.9985444056449032
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,13466,84,0.97 [0.81-1.18],0.7886468994105306
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,13466,84,0.95 [0.75-1.21],0.7009626863974605
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,13241,84,0.96 [0.77-1.21],0.744161285135972
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,11399,68,0.80 [0.45-1.42],0.4521228436810065
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,13438,83,1.03 [0.84-1.27],0.7847937262347295
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,13320,81,1.07 [0.86-1.33],0.5708570529418397
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,11500,71,1.59 [0.90-2.83],0.1134931010534005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,13686,86,0.83 [0.43-1.60],0.5769543908589954
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,11742,71,0.87 [0.41-1.85],0.7245092455360898
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,11487,69,1.27 [0.96-1.68],0.0961338029214756
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,11742,71,1.25 [0.58-2.70],0.5609215956009366
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,13208,80,0.87 [0.74-1.01],0.062765853172207
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",11399,68,0.98 [0.55-1.75],0.9482194189625778
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,11661,71,1.13 [0.85-1.49],0.3980893055412949
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,13208,80,1.03 [0.82-1.30],0.8069703625905318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,11378,66,1.45 [0.92-2.27],0.1069681810189095
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,13584,86,1.59 [0.68-3.75],0.2872843667183479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,11403,65,1.00 [0.44-2.27],0.9958286516417698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,11471,69,1.11 [0.91-1.36],0.2965851246545518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,11399,68,0.81 [0.45-1.48],0.4974989340107698
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,11487,69,1.19 [0.73-1.93],0.4826028958357355
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,11750,70,2.37 [0.89-6.34],0.0854384455315773
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,11396,68,1.05 [0.72-1.53],0.8151688247771545
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,13486,85,1.09 [0.85-1.41],0.4801149934028231
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,13589,85,1.07 [0.76-1.52],0.6807778091801409
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,13508,85,0.66 [0.41-1.08],0.0975416120017771
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,13474,86,1.28 [0.72-2.25],0.4004917153942846
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,13534,86,0.71 [0.40-1.26],0.2462156657003156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,13576,86,2.06 [1.37-3.09],0.0005274411174697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,11661,71,1.03 [0.85-1.25],0.7399592283256449
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,13534,81,0.90 [0.59-1.37],0.6250449219473697
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,13681,85,1.07 [0.66-1.74],0.7739370630917587
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,11661,71,0.90 [0.59-1.37],0.6162140670756784
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,13435,86,1.40 [0.71-2.75],0.3269006335460216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,11403,65,0.87 [0.29-2.66],0.8073016512355099
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,13584,86,0.95 [0.50-1.81],0.884174076290553
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,13714,86,1.21 [0.66-2.19],0.5416138414348011
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,13530,82,1.04 [0.81-1.34],0.7675014736634593
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,11739,71,0.75 [0.30-1.85],0.5304378739503359
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,11293,67,1.09 [0.87-1.37],0.4385903353536818
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,13551,82,0.90 [0.44-1.85],0.7772743926389043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,13553,85,1.09 [0.67-1.78],0.7271598684264499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,13524,86,1.64 [1.09-2.48],0.0178591859876752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,13500,81,1.51 [0.83-2.75],0.1775393659618185
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,13320,81,1.05 [0.63-1.76],0.8553172684884509
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,11378,66,1.09 [0.92-1.29],0.3191365790581016
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,11319,63,1.08 [0.54-2.15],0.8266164616955005
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,11644,70,0.94 [0.73-1.22],0.6437781670392174
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,13681,85,1.89 [0.95-3.75],0.0682980776659525
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,13178,80,1.00 [0.85-1.18],0.9854822657722212
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,13714,86,0.89 [0.59-1.35],0.5771522680418828
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",13179,80,1.06 [0.70-1.61],0.7811529821967216
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,11487,69,1.44 [0.92-2.26],0.1129595218081225
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,13563,86,0.92 [0.60-1.42],0.720777310666328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,11742,71,0.81 [0.46-1.45],0.4862727128653729
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,11705,70,0.97 [0.75-1.27],0.8353066642974173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,13353,83,1.03 [0.53-2.02],0.9313420439486584
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,11742,71,1.09 [0.51-2.30],0.8285891571349989
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,13610,85,1.03 [0.89-1.18],0.7033354395219114
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,13553,85,0.60 [0.36-0.99],0.0445972645213183
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,13506,82,0.76 [0.32-1.84],0.5484948983822235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,13584,86,0.99 [0.79-1.24],0.9136389049974002
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,11396,68,1.00 [0.60-1.66],0.996526976170075
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",11487,69,1.40 [0.98-2.01],0.0657095544289511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,11403,65,2.05 [0.99-4.25],0.0530202205588422
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,11487,69,1.87 [0.74-4.74],0.1858909586656764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,13708,85,0.84 [0.63-1.13],0.2538635680636941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,11403,65,1.26 [0.55-2.92],0.5828830037838636
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,11399,68,1.03 [0.67-1.57],0.8992859266962491
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,11487,69,1.18 [0.82-1.70],0.3710110489974022
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,11378,66,0.75 [0.40-1.38],0.3498114264304068
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,11378,66,0.52 [0.28-0.94],0.0298455362596303
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,11676,70,0.97 [0.78-1.21],0.8094155314707361
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,11661,71,0.94 [0.68-1.30],0.7280921221821628
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,11416,69,0.96 [0.66-1.38],0.8196592834000798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,11723,70,0.81 [0.47-1.42],0.4646511050512245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,11316,67,0.91 [0.50-1.65],0.7598782646381346
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,11396,68,1.03 [0.77-1.38],0.8501555449006798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,11677,70,1.12 [0.63-2.00],0.6993868662910707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,13485,85,1.01 [0.82-1.24],0.9573295915012088
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,13396,82,0.92 [0.55-1.53],0.7449114132806087
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,13553,85,0.99 [0.77-1.27],0.9184157117393328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,13563,86,1.22 [0.83-1.80],0.3093096888098123
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,13300,81,0.79 [0.44-1.43],0.4336155986582896
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,11676,70,1.04 [0.66-1.65],0.8671713920951334
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,13286,80,1.04 [0.60-1.79],0.8904340041057272
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,11469,67,0.88 [0.61-1.28],0.4974205794977219
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,13466,84,0.96 [0.52-1.76],0.8883955573711038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,13466,84,1.23 [0.92-1.66],0.1625827555999245
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,13560,86,1.29 [0.87-1.94],0.2075201833032677
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,13708,85,0.81 [0.47-1.38],0.4361342356143617
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,13547,84,0.73 [0.38-1.41],0.3479076496615981
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,13584,86,1.03 [0.58-1.81],0.9306688619202592
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13572,84,0.74 [0.39-1.41],0.3587033441507276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,13286,80,1.10 [0.68-1.79],0.6952459915963161
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,13572,84,0.87 [0.45-1.69],0.6850249192523663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,11469,67,0.57 [0.32-1.03],0.0627860566017977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,13675,85,0.83 [0.43-1.61],0.5839223541370759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,13553,85,1.14 [0.57-2.29],0.7058744305928171
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,13553,85,0.88 [0.49-1.58],0.6652597709461251
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,13681,85,1.10 [0.55-2.21],0.7896377446504621
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,13681,85,0.84 [0.49-1.43],0.5126382218828003
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,13466,84,1.18 [0.83-1.70],0.3582342133859041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,13681,85,0.70 [0.45-1.11],0.1284335862324248
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,13466,84,0.68 [0.40-1.17],0.1638610865493851
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,13708,85,1.11 [0.54-2.30],0.775996816115821
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,13534,81,1.32 [0.96-1.81],0.0858683447893168
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,13708,85,0.78 [0.41-1.47],0.4388510489069038
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,13610,85,1.17 [0.57-2.43],0.6693098275933467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13684,86,1.03 [0.50-2.13],0.9409307546154884
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,13466,84,1.04 [0.74-1.45],0.8338187963655923
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,11721,71,1.40 [0.78-2.52],0.265156605389273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,11705,70,1.06 [0.82-1.36],0.6543960645796179
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,11721,71,0.90 [0.54-1.49],0.6722957003577118
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",13320,81,1.06 [0.83-1.36],0.6374209512629718
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,11487,69,1.22 [0.65-2.27],0.5388387437128345
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,13466,84,0.95 [0.60-1.49],0.8100756724876093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,13553,85,1.26 [0.61-2.63],0.534259734595752
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,11742,71,0.92 [0.68-1.23],0.5718188922199499
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,11676,70,1.20 [0.98-1.48],0.0848348613278934
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",11316,67,0.75 [0.43-1.30],0.2975149205278478
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,11403,65,1.07 [0.79-1.44],0.666018985853235
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,11416,69,1.18 [0.81-1.73],0.3809350941780348
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,13241,84,1.13 [0.72-1.75],0.5993934450417879
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,11403,65,0.87 [0.66-1.15],0.3315619931736298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,11212,67,0.88 [0.56-1.36],0.5527644268203489
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,13320,81,1.55 [1.03-2.35],0.0364246665530725
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,11399,68,1.17 [0.60-2.28],0.6485041800769541
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,11399,68,0.66 [0.34-1.28],0.2173572772301952
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,11469,67,0.95 [0.77-1.17],0.5980726078848217
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,11742,71,0.60 [0.26-1.37],0.2231865099057396
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,11378,66,0.56 [0.29-1.08],0.0813166618825995
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,13241,84,1.14 [0.89-1.46],0.2986993704122298
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,13466,83,1.23 [0.84-1.81],0.2871002236358749
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,11487,69,1.14 [0.89-1.46],0.2886694909980948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,13208,80,0.80 [0.46-1.39],0.4240209688343199
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,11378,66,1.12 [0.75-1.66],0.5833790112390318
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,11316,67,1.01 [0.70-1.44],0.9752833720056912
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,13683,84,0.85 [0.59-1.22],0.3656660351305812
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,11723,70,1.07 [0.61-1.86],0.8126258855648043
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,11403,65,0.42 [0.16-1.15],0.0911379233120645
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,13286,80,0.97 [0.71-1.30],0.8168114478182721
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,13534,81,1.14 [0.87-1.49],0.351939531654862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",11403,65,0.95 [0.50-1.81],0.8870673981957253
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,11378,66,0.90 [0.53-1.53],0.70359479140357
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,11487,69,1.13 [0.88-1.46],0.3331213869757014
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,11721,71,1.14 [0.84-1.54],0.4129801137821408
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,13547,84,0.74 [0.51-1.07],0.1075617330489563
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,11739,71,0.87 [0.57-1.34],0.5378090983061723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,13553,85,0.84 [0.46-1.51],0.5575279014115806
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,13675,85,0.94 [0.70-1.27],0.7004750825848323
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,13534,81,1.08 [0.84-1.40],0.5393342159433339
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,11461,69,1.15 [0.84-1.58],0.3894340959145728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,11676,70,0.94 [0.76-1.16],0.5769011099645328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,11316,67,0.92 [0.60-1.42],0.718906115762862
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,11399,68,1.11 [0.81-1.52],0.5019369698182511
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,13534,81,1.07 [0.86-1.34],0.5467619904235544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,11661,71,1.07 [0.82-1.39],0.6153376456890916
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,11378,66,1.07 [0.70-1.61],0.7630529918965046
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,11403,65,1.01 [0.75-1.37],0.9258831554095532
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,11723,70,1.04 [0.75-1.45],0.8005740612724671
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,13551,82,1.12 [0.89-1.41],0.331987085792167
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,13320,81,1.26 [0.97-1.64],0.0793884250379941
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,11378,66,0.86 [0.47-1.56],0.6158476304518006
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,13320,81,2.05 [1.40-3.00],0.0002374941808037
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,11378,66,1.17 [0.82-1.67],0.3897712532087093
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,11396,68,0.92 [0.70-1.21],0.5581691699703764
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,11676,70,0.87 [0.69-1.10],0.2372696838461753
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,11403,65,1.01 [0.56-1.81],0.9783152654762328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,13192,80,0.94 [0.72-1.22],0.6498490812242153
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,11399,68,0.97 [0.61-1.55],0.9034572540188708
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTN,Titin,11378,66,1.03 [0.74-1.45],0.8481736471819101
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,11614,69,0.88 [0.36-2.13],0.7744231319562439
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,11396,68,0.58 [0.24-1.36],0.2064766241853479
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,11721,71,0.92 [0.71-1.20],0.5504351502168647
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,11487,69,1.11 [0.85-1.47],0.4450721990158889
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,13466,84,0.98 [0.79-1.21],0.8170703775265571
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,11528,71,0.95 [0.56-1.60],0.8465761045029047
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,13584,86,0.96 [0.48-1.95],0.9181702860410156
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,13681,85,0.94 [0.71-1.24],0.6390029360116822
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,11705,70,1.06 [0.70-1.59],0.7970669687919811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,11375,68,1.00 [0.79-1.27],0.9727645143439344
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",13553,85,0.99 [0.66-1.48],0.9612084354930328
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,13471,81,0.90 [0.67-1.20],0.4640544931041421
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,13551,82,0.83 [0.42-1.65],0.601144740836514
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",11403,65,0.80 [0.54-1.18],0.2552152461184512
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,13485,85,1.28 [0.76-2.18],0.3516890118011481
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,11661,71,0.82 [0.37-1.83],0.6301324565853845
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,11742,71,0.87 [0.60-1.26],0.4617565524554996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,11403,65,1.14 [0.80-1.65],0.4676034860389683
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,11378,66,1.25 [0.82-1.89],0.2971627170593122
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,11469,67,1.02 [0.73-1.42],0.9199457101733728
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,11676,70,1.01 [0.86-1.19],0.8595969384276797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,11378,66,1.10 [0.91-1.35],0.3288517846220974
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,11378,66,0.53 [0.23-1.24],0.1423109619559531
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,13466,84,1.43 [0.87-2.36],0.1634887046833173
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,13672,86,1.03 [0.73-1.47],0.8555478469873977
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,11403,65,0.92 [0.38-2.24],0.8621702906050556
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,11316,67,0.81 [0.52-1.27],0.3576929163392826
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,11661,71,0.79 [0.40-1.57],0.5018007648797412
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,11742,71,1.04 [0.83-1.32],0.7163351737266948
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,11396,68,0.77 [0.46-1.28],0.3053498330120336
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,11473,69,0.97 [0.62-1.52],0.889559180567549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,11469,67,1.00 [0.72-1.39],0.9920905849695536
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,11399,68,1.07 [0.77-1.48],0.700280631677273
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,13485,85,0.97 [0.79-1.20],0.7870796967289808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,11661,71,1.07 [0.78-1.45],0.6842445194830518
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,11705,70,0.77 [0.39-1.52],0.4500512960934104
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,11378,66,0.93 [0.69-1.25],0.6225470327181722
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,13320,81,1.02 [0.83-1.24],0.8832161975625066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,13241,84,1.22 [0.90-1.66],0.1919503342239313
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,13320,81,1.37 [1.04-1.80],0.0268505499912787
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,11403,65,0.96 [0.73-1.26],0.7665310157863745
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,13534,81,0.95 [0.75-1.20],0.6488590304813961
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,13300,85,1.57 [0.78-3.16],0.2055695873929897
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,11739,71,0.95 [0.70-1.30],0.7654913887070285
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,13485,85,0.96 [0.37-2.48],0.9324641850274672
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,11396,68,0.94 [0.74-1.18],0.588811506557723
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,13545,86,1.40 [0.71-2.77],0.3310074349638294
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,13681,85,1.65 [0.87-3.11],0.122300002906893
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,11316,67,1.03 [0.80-1.32],0.8255256422661338
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,13667,85,1.02 [0.74-1.41],0.8887370515007808
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,11403,65,1.93 [0.91-4.11],0.0886910687314041
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,13584,86,1.05 [0.75-1.45],0.7916673202343549
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,13687,85,1.13 [0.64-1.99],0.6656188372919276
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,11723,70,1.09 [0.50-2.36],0.8270805475072271
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,13320,81,1.00 [0.85-1.19],0.9694201875716432
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,11416,69,0.51 [0.18-1.42],0.1958373195219484
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,11742,71,1.07 [0.58-1.98],0.831616258530377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,13485,85,1.00 [0.75-1.33],0.9851763127136486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,11739,71,1.06 [0.78-1.44],0.7036057332898467
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,13485,85,0.89 [0.59-1.35],0.5868561102737395
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,11487,69,0.96 [0.68-1.36],0.8128568613021224
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,13485,85,1.12 [0.88-1.41],0.3595134109739859
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,11661,71,0.90 [0.71-1.14],0.365820300370021
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,13485,85,0.97 [0.75-1.24],0.7979826579300249
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,11661,71,0.84 [0.44-1.62],0.6036366931975805
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,11378,66,0.42 [0.19-0.95],0.0365666595379486
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,11661,71,0.96 [0.63-1.46],0.8576254164724377
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,13530,85,1.01 [0.60-1.70],0.9764410297522996
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,13533,82,0.82 [0.59-1.14],0.2410365853331544
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,11705,70,1.05 [0.58-1.91],0.8809778895487127
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,13208,80,1.22 [0.83-1.81],0.3163195183537663
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,11487,69,1.07 [0.64-1.79],0.7864127391100946
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,13320,81,1.00 [0.71-1.40],0.9872974218311548
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,13681,85,0.99 [0.76-1.28],0.9390147472669594
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,13241,84,1.50 [0.89-2.50],0.1248700642337385
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,11469,67,1.01 [0.68-1.49],0.9775935966716128
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,13654,85,0.90 [0.57-1.43],0.6626136298333567
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,11316,67,0.94 [0.69-1.29],0.7194959587463112
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,13415,83,0.97 [0.58-1.62],0.9106423892729836
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,11723,70,1.28 [0.95-1.72],0.1023054800418222
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,13714,86,0.99 [0.76-1.28],0.933669490655418
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",13553,85,0.83 [0.50-1.39],0.4742263311834297
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,13286,80,0.92 [0.69-1.25],0.6028660528069856
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,13320,81,1.06 [0.86-1.31],0.5887251155754707
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,13208,80,1.08 [0.85-1.38],0.5108672902628655
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,11705,70,1.04 [0.78-1.39],0.8034058656879721
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,11403,65,0.66 [0.41-1.07],0.0903247276151759
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,11661,71,0.90 [0.49-1.66],0.7283452236741936
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,11447,69,1.31 [0.95-1.82],0.1004568884785407
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,13656,85,1.01 [0.75-1.36],0.9392369264445724
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,12827,82,2.36 [1.48-3.77],0.0003260703941327
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",13428,82,1.84 [1.17-2.91],0.0083095292533829
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",13572,84,1.10 [0.63-1.93],0.726456506049568
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,13675,85,1.47 [0.84-2.56],0.1733016393044296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,13286,80,0.55 [0.27-1.15],0.1105639659374741
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,13466,84,1.05 [0.74-1.49],0.765044783762811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,13675,85,1.14 [0.83-1.55],0.4212676209745066
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,13642,86,1.53 [0.80-2.92],0.2032998654901358
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,11403,65,1.08 [0.72-1.61],0.710163961853107
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,13584,86,0.89 [0.72-1.09],0.2634515627514798
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,13208,80,1.02 [0.60-1.73],0.9501468411288988
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,11705,70,1.87 [0.84-4.14],0.1247348438670508
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",11676,70,1.01 [0.87-1.18],0.9015734752833652
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,13485,85,0.97 [0.83-1.15],0.758189769804993
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,11661,71,1.01 [0.50-2.04],0.9692204256405926
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,11378,66,1.10 [0.76-1.58],0.6164249006971982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,13286,80,1.00 [0.80-1.26],0.9771324545039471
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,11469,67,0.92 [0.67-1.27],0.6171427522190958
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,11403,65,0.96 [0.40-2.28],0.917709376093398
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,11403,65,0.83 [0.44-1.58],0.577880219655309
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,13241,84,1.03 [0.78-1.36],0.856337978614399
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,13320,81,1.14 [0.73-1.79],0.5568960283903939
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,11378,66,1.06 [0.74-1.54],0.7409848923194017
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,11676,70,0.90 [0.70-1.16],0.4185799762491686
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,11705,70,1.07 [0.59-1.95],0.8242127115946811
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,11403,65,0.70 [0.33-1.50],0.3601172863298982
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,11487,69,1.20 [0.87-1.65],0.2620112482483947
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,11661,71,1.11 [0.87-1.43],0.3961311525447296
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,11676,70,1.23 [0.90-1.69],0.1865054848505287
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,11661,71,1.14 [0.78-1.68],0.4986179978656797
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,11416,69,1.02 [0.93-1.12],0.6745311423661615
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,11316,67,0.87 [0.41-1.85],0.7249771593526315
Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,11396,68,1.03 [0.82-1.29],0.8223796965769392
